Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
PLoS One
    January 2021
  1. MITCHELL G, Leonard L, Carter G, Santin O, et al
    Evaluation of a 'serious game' on nursing student knowledge and uptake of influenza vaccination.
    PLoS One. 2021;16:e0245389.
    >> Share

  2. SONGANE M, Grossmann V
    The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value.
    PLoS One. 2021;16:e0244722.
    >> Share

  3. KAINGA HW, Ssendagire S, Ssanyu JN, Nabukeera S, et al
    Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
    PLoS One. 2021;16:e0243137.
    >> Share

  4. BARAL R, Levin A, Odero C, Pecenka C, et al
    Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
    PLoS One. 2021;16:e0244995.
    >> Share

  5. MPOFU R, Otwombe K, Mlisana K, Nchabeleng M, et al
    Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.
    PLoS One. 2021;16:e0241708.
    >> Share

  6. ATTWELL K, Lake J, Sneddon J, Gerrans P, et al
    Converting the maybes: Crucial for a successful COVID-19 vaccination strategy.
    PLoS One. 2021;16:e0245907.
    >> Share

  7. RODGERS LR, Streeter AJ, Lin N, Hamilton W, et al
    Impact of influenza vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using primary care data.
    PLoS One. 2021;16:e0246156.
    >> Share

  8. ARNOLD ME, Courcier EA, Stringer LA, McCormick CM, et al
    A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).
    PLoS One. 2021;16:e0246141.
    >> Share

  9. PRAYITNO A, Supriyatno B, Munasir Z, Karuniawati A, et al
    Pneumococcal nasopharyngeal carriage in Indonesia infants and toddlers post-PCV13 vaccination in a 2+1 schedule: A prospective cohort study.
    PLoS One. 2021;16:e0245789.
    >> Share

  10. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination in healthcare workers, Honduras.
    PLoS One. 2021;16:e0246379.
    >> Share

  11. SIMWAKA J, Seheri M, Mulundu G, Kaonga P, et al
    Rotavirus breakthrough infections responsible for gastroenteritis in vaccinated infants who presented with acute diarrhoea at University Teaching Hospitals, Children's Hospital in 2016, in Lusaka Zambia.
    PLoS One. 2021;16:e0246025.
    >> Share

  12. ASHFAQ UA, Saleem S, Masoud MS, Ahmad M, et al
    Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approach.
    PLoS One. 2021;16:e0245072.
    >> Share

  13. LOPEZ MORENO G, Nirmala J, Goodell C, Culhane M, et al
    Shedding and transmission of a live attenuated influenza A virus vaccine in pre-weaned pigs under field conditions.
    PLoS One. 2021;16:e0246690.
    >> Share

  14. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras.
    PLoS One. 2021;16:e0246385.
    >> Share

  15. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination among older adults in nursing homes and daycare centers, Honduras.
    PLoS One. 2021;16:e0246382.
    >> Share

  16. VANNI T, Thome BDC, Oliveira MMM, Gattas VL, et al
    Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups.
    PLoS One. 2021;16:e0246540.
    >> Share

  17. GOUGLAS D, Marsh K
    Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysis.
    PLoS One. 2021;16:e0246235.
    >> Share

  18. TERMRUNGRUANGLERT W, Khemapech N, Vasuratna A, Havanond P, et al
    The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand.
    PLoS One. 2021;16:e0245894.
    >> Share

  19. CHANIE MG, Ewunetie GE, Molla A, Muche A, et al
    Determinants of vaccination dropout among children 12-23 months age in north Gondar zone, northwest Ethiopia, 2019.
    PLoS One. 2021;16:e0246018.
    >> Share

  20. LATKIN CA, Dayton L, Yi G, Colon B, et al
    Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US.
    PLoS One. 2021;16:e0246970.
    >> Share

  21. LEE J, Yoon Y, Kim EJ, Lee D, et al
    23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method.
    PLoS One. 2021;16:e0246699.
    >> Share

  22. KOZAKOVA J, Krizova P, Maly M
    Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
    PLoS One. 2021;16:e0247862.
    >> Share

  23. WAGAI JN, Rhoda D, Prier M, Trimmer MK, et al
    Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    PLoS One. 2021;16:e0247415.
    >> Share

  24. MOHAMMED SA, Workneh BD, Kahissay MH
    Knowledge, attitude and practice of vaccinators and vaccine handlers on vaccine cold chain management in public health facilities, Ethiopia: Cross-sectional study.
    PLoS One. 2021;16:e0247459.
    >> Share

  25. FORGACS D, Abreu RB, Sautto GA, Kirchenbaum GA, et al
    Convergent antibody evolution and clonotype expansion following influenza virus vaccination.
    PLoS One. 2021;16:e0247253.
    >> Share

  26. MATTER D, Potgieter L
    Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures.
    PLoS One. 2021;16:e0248053.
    >> Share

  27. XU Z, Wu B, Topcu U
    Control strategies for COVID-19 epidemic with vaccination, shield immunity and quarantine: A metric temporal logic approach.
    PLoS One. 2021;16:e0247660.
    >> Share

  28. GUADIANA D, Kavanagh NM, Squarize CH
    Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.
    PLoS One. 2021;16:e0248047.
    >> Share

    A study on the effects of containment policies and vaccination on the spread of SARS-CoV-2.
    PLoS One. 2021;16:e0247439.
    >> Share

  30. GERMANI F, Biller-Andorno N
    The anti-vaccination infodemic on social media: A behavioral analysis.
    PLoS One. 2021;16:e0247642.
    >> Share

  31. KARDANI K, Bolhassani A
    Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
    PLoS One. 2021;16:e0247396.
    >> Share

  32. DE LUSIGNAN S, Hoang U, Liyanage H, Tripathy M, et al
    Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network.
    PLoS One. 2021;16:e0248123.
    >> Share

  33. JANG H, Ross TM
    Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles.
    PLoS One. 2021;16:e0246613.
    >> Share

  34. OTIANG E, Thumbi SM, Campbell ZA, Njagi LW, et al
    Impact of routine Newcastle disease vaccination on chicken flock size in smallholder farms in western Kenya.
    PLoS One. 2021;16:e0248596.
    >> Share

  35. CHUKWUDOZIE OS, Gray CM, Fagbayi TA, Chukwuanukwu RC, et al
    Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    PLoS One. 2021;16:e0248061.
    >> Share

  36. SHINJOH M, Sugaya N, Yamaguchi Y, Ookawara I, et al
    Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season.
    PLoS One. 2021;16:e0249005.
    >> Share

  37. KURU O, Stecula D, Lu H, Ophir Y, et al
    The effects of scientific messages and narratives about vaccination.
    PLoS One. 2021;16:e0248328.
    >> Share

  38. EDWARDS B, Biddle N, Gray M, Sollis K, et al
    COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.
    PLoS One. 2021;16:e0248892.
    >> Share

  39. PROMPETCHARA E, Ketloy C, Tharakhet K, Kaewpang P, et al
    DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.
    PLoS One. 2021;16:e0248007.
    >> Share

  40. KONDO KUNIEDA M, Manzo ML, Shibanuma A, Jimba M, et al
    Rapidly modifiable factors associated with full vaccination status among children in Niamey, Niger: A cross-sectional, random cluster household survey.
    PLoS One. 2021;16:e0249026.
    >> Share

  41. ACACIO S, Nhampossa T, Quinto L, Vubil D, et al
    Rotavirus disease burden pre-vaccine introduction in young children in Rural Southern Mozambique, an area of high HIV prevalence.
    PLoS One. 2021;16:e0249714.
    >> Share

  42. EYTHORSSON E, Asgeirsdottir TL, Erlendsdottir H, Hrafnkelsson B, et al
    The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis.
    PLoS One. 2021;16:e0249497.
    >> Share

  43. STUURMAN AL, Rizzo C, Haag M
    Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe.
    PLoS One. 2021;16:e0248943.
    >> Share

  44. ACEVEDO-VILLANUEVA K, Renu S, Gourapura R, Selvaraj R, et al
    Efficacy of a nanoparticle vaccine administered in-ovo against Salmonella in broilers.
    PLoS One. 2021;16:e0247938.
    >> Share

  45. RAZA MT, Mizan S, Yasmin F, Akash AS, et al
    Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).
    PLoS One. 2021;16:e0248001.
    >> Share

  46. RIOS-BLANCAS MJ, Lamadrid-Figueroa H, Betancourt-Cravioto M, Lozano R, et al
    Vaccination coverage estimation in Mexico in children under five years old: Trends and associated factors.
    PLoS One. 2021;16:e0250172.
    >> Share

  47. FRIDMAN A, Gershon R, Gneezy A
    COVID-19 and vaccine hesitancy: A longitudinal study.
    PLoS One. 2021;16:e0250123.
    >> Share

  48. ASSEN AM, Walkden-Brown SW, Stillman M, Alfirevich S, et al
    Comparison of tracheal and choanal cleft swabs and poultry dust samples for detection of Newcastle disease virus and infectious bronchitis virus genome in vaccinated meat chicken flocks.
    PLoS One. 2021;16:e0247729.
    >> Share

  49. OYO-ITA A, Bosch-Capblanch X, Ross A, Oku A, et al
    Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
    PLoS One. 2021;16:e0248236.
    >> Share

  50. Expression of Concern: Recombinant M2e Protein-Based ELISA: A Novel and Inexpensive Approach for Differentiating Avian Influenza Infected Chickens from Vaccinated Ones.
    PLoS One. 2021;16:e0250485.
    >> Share

  51. GONCALVES P, Saez-Lopez E, Carneiro S, Simoes MJ, et al
    Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme.
    PLoS One. 2021;16:e0250103.
    >> Share

  52. NJUMA LIBWEA J, A Fletcher M, Koki Ndombo P, Boula A, et al
    Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children <5 years in Cameroon, 2011-2018.
    PLoS One. 2021;16:e0250010.
    >> Share

  53. EDER M, Omic H, Gorges J, Badt F, et al
    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.
    PLoS One. 2021;16:e0249785.
    >> Share

  54. EL-ELIMAT T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, et al
    Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan.
    PLoS One. 2021;16:e0250555.
    >> Share

  55. BARAL R, Levin A, Odero C, Pecenka C, et al
    Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
    PLoS One. 2021;16:e0250863.
    >> Share

  56. ADIL MAHMOUD YOUSIF N, Tsoungui Obama HCJ, Ngucho Mbeutchou YJ, Kwamou Ngaha SF, et al
    The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.
    PLoS One. 2021;16:e0245417.
    >> Share

  57. COUDEVILLE L, Jollivet O, Mahe C, Chaves S, et al
    Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    PLoS One. 2021;16:e0250797.
    >> Share

  58. ABEDIN M, Islam MA, Rahman FN, Reza HM, et al
    Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage.
    PLoS One. 2021;16:e0250495.
    >> Share

  59. QIN W, Wang E, Ni Z
    Chinese consumers' willingness to get a COVID-19 vaccine and willingness to pay for it.
    PLoS One. 2021;16:e0250112.
    >> Share

  60. KARUNARATNE ND, Newkirk RW, Ames NP, Van Kessel AG, et al
    Effects of exogenous beta-glucanase on ileal digesta soluble beta-glucan molecular weight, digestive tract characteristics, and performance of coccidiosis vaccinated broiler chickens fed hulless barley-based diets with and without medication.
    PLoS One. 2021;16:e0236231.
    >> Share

  61. BAUM U, Kulathinal S, Auranen K
    Exposure misclassification bias in the estimation of vaccine effectiveness.
    PLoS One. 2021;16:e0251622.
    >> Share

  62. WOLFF E, Widgren K, Scalia Tomba G, Roth A, et al
    Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    PLoS One. 2021;16:e0251644.
    >> Share

  63. YOUNG LS, Danial Z
    Three pre-vaccine responses to Covid-like epidemics.
    PLoS One. 2021;16:e0251349.
    >> Share

  64. ISLAM MS, Kamal AM, Kabir A, Southern DL, et al
    COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence.
    PLoS One. 2021;16:e0251605.
    >> Share

  65. PILTCH-LOEB R, Savoia E, Goldberg B, Hughes B, et al
    Examining the effect of information channel on COVID-19 vaccine acceptance.
    PLoS One. 2021;16:e0251095.
    >> Share

  66. GRAEBER D, Schmidt-Petri C, Schroder C
    Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany.
    PLoS One. 2021;16:e0248372.
    >> Share

  67. SANO K, Saito S, Suzuki T, Kotani O, et al
    An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody.
    PLoS One. 2021;16:e0245244.
    >> Share

  68. GENTILE A, Giglio N, Lucion MF, Martinez AC, et al
    Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
    PLoS One. 2021;16:e0251496.
    >> Share

  69. ELIZONDO-ALZOLA U, G Carrasco M, Pinos L, Picchio CA, et al
    Vaccine hesitancy among paediatric nurses: Prevalence and associated factors.
    PLoS One. 2021;16:e0251735.
    >> Share

  70. LEVINE G, Salifu A, Mohammed I, Fink G, et al
    Mobile nudges and financial incentives to improve coverage of timely neonatal vaccination in rural areas (GEVaP trial): A 3-armed cluster randomized controlled trial in Northern Ghana.
    PLoS One. 2021;16:e0247485.
    >> Share

  71. ATUHAIRE DK, Muleya W, Mbao V, Niyongabo J, et al
    Molecular characterization and population genetics of Theileria parva in Burundi's unvaccinated cattle: Towards the introduction of East Coast fever vaccine.
    PLoS One. 2021;16:e0251500.
    >> Share

  72. CAINI S, Paget J, Spreeuwenberg P, Korevaar JC, et al
    Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees.
    PLoS One. 2021;16:e0249883.
    >> Share

  73. EZAJ MMA, Haque MS, Syed SB, Khan MSA, et al
    Comparative proteomic analysis to annotate the structural and functional association of the hypothetical proteins of S. maltophilia k279a and predict potential T and B cell targets for vaccination.
    PLoS One. 2021;16:e0252295.
    >> Share

  74. ZEIGLER DF, Gage E, Clegg CH
    Epitope-targeting platform for broadly protective influenza vaccines.
    PLoS One. 2021;16:e0252170.
    >> Share

  75. KITONSA J, Kamacooko O, Bahemuka UM, Kibengo F, et al
    Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda.
    PLoS One. 2021;16:e0251992.
    >> Share

  76. CHE X, Liu Y, Wang J, Xu Y, et al
    Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
    PLoS One. 2021;16:e0251567.
    >> Share

  77. NIKOLOVSKI J, Koldijk M, Weverling GJ, Spertus J, et al
    Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults.
    PLoS One. 2021;16:e0251963.
    >> Share

  78. NAKPHOOK S, Patumanond J, Shrestha M, Prasert K, et al
    Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
    PLoS One. 2021;16:e0253028.
    >> Share

  79. KHOU C, Diaz-Salinas MA, da Costa A, Prehaud C, et al
    Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.
    PLoS One. 2021;16:e0252595.
    >> Share

  80. KAHANA D, Yamin D
    Accounting for the spread of vaccination behavior to optimize influenza vaccination programs.
    PLoS One. 2021;16:e0252510.
    >> Share

  81. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0252332.
    >> Share

  82. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    >> Share

  83. STUURMAN AL, Ciampini S, Vannacci A, Bella A, et al
    Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.
    PLoS One. 2021;16:e0252836.
    >> Share

  84. STRODEL R, Dayton L, Garrison-Desany HM, Eber G, et al
    COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans.
    PLoS One. 2021;16:e0253208.
    >> Share

  85. LINKS IJ, Denholm LJ, Evers M, Kingham LJ, et al
    Is vaccination a viable method to control Johne's disease caused by Mycobacterium avium subsp. paratuberculosis? Data from 12 million ovine vaccinations and 7.6 million carcass examinations in New South Wales, Australia from 1999-2009.
    PLoS One. 2021;16:e0246411.
    >> Share

  86. PALMER EA, Penagaricano F, Vedovatto M, Oliveira RA, et al
    Effects of maternal gestational diet, with or without methionine, on muscle transcriptome of Bos indicus-influenced beef calves following a vaccine-induced immunological challenge.
    PLoS One. 2021;16:e0253810.
    >> Share

  87. RIVIERE C, Bell T, Cadot Y, Perodin C, et al
    Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti.
    PLoS One. 2021;16:e0252310.
    >> Share

  88. HANDEBO S, Wolde M, Shitu K, Kassie A, et al
    Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.
    PLoS One. 2021;16:e0253499.
    >> Share

  89. WARIRI O, Okomo U, Kwarshak YK, Murray KA, et al
    Timeliness of routine childhood vaccination in low- and middle-income countries, 1978-2021: Protocol for a scoping review to map methodologic gaps and determinants.
    PLoS One. 2021;16:e0253423.
    >> Share

  90. WAGAI JN, Rhoda DA, Prier ML, Trimner MK, et al
    Correction: Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    PLoS One. 2021;16:e0253670.
    >> Share

  91. KHAN MT, Islam R, Jerin TJ, Mahmud A, et al
    Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus.
    PLoS One. 2021;16:e0253393.
    >> Share

  92. TUNGGAL HC, Munson PV, O'Connor MA, Hajari N, et al
    Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs.
    PLoS One. 2021;16:e0253265.
    >> Share

  93. WISNEWSKI AV, Campillo Luna J, Redlich CA
    Human IgG and IgA responses to COVID-19 mRNA vaccines.
    PLoS One. 2021;16:e0249499.
    >> Share

  94. SPARGO RM, Coetzer A, Makuvadze FT, Chikerema SM, et al
    Knowledge, attitudes and practices towards rabies: A survey of the general population residing in the Harare Metropolitan Province of Zimbabwe.
    PLoS One. 2021;16:e0246103.
    >> Share

  95. MCKUNE S, Serra R, Toure A
    Gender and intersectional analysis of livestock vaccine value chains in Kaffrine, Senegal.
    PLoS One. 2021;16:e0252045.
    >> Share

  96. RUJUMBA J, Akugizibwe M, Basta NE, Banura C, et al
    Why don't adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: Perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers.
    PLoS One. 2021;16:e0253735.
    >> Share

  97. THANEE C, Kittikraisak W, Sinthuwattanawibool C, Roekworachai K, et al
    Knowledge, attitude/perception, and practice related to seasonal influenza vaccination among caregivers of young Thai children: A cross-sectional study.
    PLoS One. 2021;16:e0253561.
    >> Share

  98. DUTTA T, Agley J, Meyerson BE, Barnes PA, et al
    Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis.
    PLoS One. 2021;16:e0253318.
    >> Share

  99. Correction: Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children <5 years in Cameroon, 2011-2018.
    PLoS One. 2021;16:e0254616.
    >> Share

  100. AJOVALASIT S, Dorgali VM, Mazza A, d'Onofrio A, et al
    Evidence of disorientation towards immunization on online social media after contrasting political communication on vaccines. Results from an analysis of Twitter data in Italy.
    PLoS One. 2021;16:e0253569.
    >> Share

  101. PAWASKAR M, Burgess C, Pillsbury M, Wisloff T, et al
    Clinical and economic impact of universal varicella vaccination in Norway: A modeling study.
    PLoS One. 2021;16:e0254080.
    >> Share

  102. DAVAHLI MR, Karwowski W, Fiok K
    Optimizing COVID-19 vaccine distribution across the United States using deterministic and stochastic recurrent neural networks.
    PLoS One. 2021;16:e0253925.
    >> Share

  103. YASSI A, Grant JM, Lockhart K, Barker S, et al
    Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    PLoS One. 2021;16:e0254920.
    >> Share

  104. STODDARD M, Sarkar S, Yuan L, Nolan RP, et al
    Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
    PLoS One. 2021;16:e0254734.
    >> Share

  105. LU M, Ishwaran H
    Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.
    PLoS One. 2021;16:e0254397.
    >> Share

  106. ALAGOZ O, Sethi AK, Patterson BW, Churpek M, et al
    The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.
    PLoS One. 2021;16:e0254456.
    >> Share

  107. AHMED MH, Kanfe SG, Jarso MH
    Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings.
    PLoS One. 2021;16:e0254391.
    >> Share

  108. KOLLI SK, Salman AM, Ramesar J, Chevalley-Maurel S, et al
    Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
    PLoS One. 2021;16:e0254498.
    >> Share

  109. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    >> Share

  110. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Retraction: Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0255347.
    >> Share

  111. DITOSTO JD, Weiss RE, Yee LM, Badreldin N, et al
    Association of Tdap vaccine guidelines with vaccine uptake during pregnancy.
    PLoS One. 2021;16:e0254863.
    >> Share

  112. ALVAREZ MM, Bravo-Gonzalez S, Trujillo-de Santiago G
    Modeling vaccination strategies in an Excel spreadsheet: Increasing the rate of vaccination is more effective than increasing the vaccination coverage for containing COVID-19.
    PLoS One. 2021;16:e0254430.
    >> Share

  113. KUHN R, Henwood B, Lawton A, Kleva M, et al
    COVID-19 vaccine access and attitudes among people experiencing homelessness from pilot mobile phone survey in Los Angeles, CA.
    PLoS One. 2021;16:e0255246.
    >> Share

  114. DEPELSENAIRE ACI, Witham K, Veitch M, Wells JW, et al
    Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.
    PLoS One. 2021;16:e0255282.
    >> Share

  115. SCORDO JM, Aguillon-Duran GP, Ayala D, Quirino-Cerrillo AP, et al
    A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.
    PLoS One. 2021;16:e0255194.
    >> Share

  116. CLAVE LLAVALL A, de Wildt G, Meza G, Tattsbridge J, et al
    Nurses' and teachers' perceived barriers and facilitators to the uptake of the Human Papilloma Virus (HPV) vaccination program in Iquitos, Peru: A qualitative study.
    PLoS One. 2021;16:e0255218.
    >> Share

  117. JOSHUA PE, Nwauzor CO, Odimegwu DC, Ukachukwu UG, et al
    Experimental and molecular predictions of the adjuvanticity of snail mucin on hepatitis B vaccine in albino mice.
    PLoS One. 2021;16:e0246915.
    >> Share

  118. CHISSAQUE A, Bauhofer AFL, Cossa-Moiane I, Sitoe E, et al
    Rotavirus A infection in pre- and post-vaccine period: Risk factors, genotypes distribution by vaccination status and age of children in Nampula Province, Northern Mozambique (2015-2019).
    PLoS One. 2021;16:e0255720.
    >> Share

  119. ABREU RB, Kirchenbaum GA, Sautto GA, Clutter EF, et al
    Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination.
    PLoS One. 2021;16:e0254421.
    >> Share

  120. MANT M, Aslemand A, Prine A, Jaagumagi Holland A, et al
    University students' perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study.
    PLoS One. 2021;16:e0255447.
    >> Share

  121. TAGHIOFF SM, Slavin BR, Holton T, Singh D, et al
    Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients.
    PLoS One. 2021;16:e0255541.
    >> Share

  122. CARCAMO DE LA CONCEPCION M, Sargent DJ, Surbanovski N, Colgan RJ, et al
    De novo sequencing and analysis of the transcriptome of two highbush blueberry (Vaccinium corymbosum L.) cultivars 'Bluecrop' and 'Legacy' at harvest and following post-harvest storage.
    PLoS One. 2021;16:e0255139.
    >> Share

  123. ALDOSSRI M, Okoronkwo C, Dodd V, Manson H, et al
    Determinants of dentists' readiness to assess HPV risk and recommend immunization: A transtheoretical model of change-based cross-sectional study of Ontario dentists.
    PLoS One. 2021;16:e0247043.
    >> Share

  124. KUMAR S, Purakayastha DR, Kapil A, Saha S, et al
    Carriage rates and antimicrobial sensitivity of pneumococci in the upper respiratory tract of children less than ten years old, in a north Indian rural community.
    PLoS One. 2021;16:e0246522.
    >> Share

  125. MOHAMED NA, Solehan HM, Mohd Rani MD, Ithnin M, et al
    Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey.
    PLoS One. 2021;16:e0256110.
    >> Share

  126. GONZALEZ-BLOCK MA, Pelcastre-Villafuerte BE, Riva Knauth D, Fachel-Leal A, et al
    Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups.
    PLoS One. 2021;16:e0256040.
    >> Share

  127. MAGEE K, Marsh IR, Turek MM, Grudzinski J, et al
    Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
    PLoS One. 2021;16:e0255798.
    >> Share

  128. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0255382.
    >> Share

  129. ZHAO X, Tatapudi H, Corey G, Gopalappa C, et al
    Threshold analyses on combinations of testing, population size, and vaccine coverage for COVID-19 control in a university setting.
    PLoS One. 2021;16:e0255864.
    >> Share

  130. PAUL A, Sikdar D, Mahanta J, Ghosh S, et al
    Peoples' understanding, acceptance, and perceived challenges of vaccination against COVID-19: A cross-sectional study in Bangladesh.
    PLoS One. 2021;16:e0256493.
    >> Share

  131. ESHUN-WILSON I, Mody A, Tram KH, Bradley C, et al
    Preferences for COVID-19 vaccine distribution strategies in the US: A discrete choice survey.
    PLoS One. 2021;16:e0256394.
    >> Share

  132. MOTTA M, Stecula D
    Quantifying the effect of Wakefield et al. (1998) on skepticism about MMR vaccine safety in the U.S.
    PLoS One. 2021;16:e0256395.
    >> Share

  133. HU W, DeMarcus LS, Sjoberg PA, Robbins AS, et al
    Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016-2017 through 2019-2020 influenza seasons.
    PLoS One. 2021;16:e0256165.
    >> Share

  134. HOPKER A, Pandey N, Bartholomew R, Blanton A, et al
    Livestock vaccination programme participation among smallholder farmers on the outskirts of National Parks and Tiger Reserves in the Indian states of Madhya Pradesh and Assam.
    PLoS One. 2021;16:e0256684.
    >> Share

  135. FATIREGUN AA, Lochlainn LN, Kabore L, Dosumu M, et al
    Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria, December 2019.
    PLoS One. 2021;16:e0252798.
    >> Share

  136. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    >> Share

  137. ABD ELHAFEEZ S, Elbarazi I, Shaaban R, ElMakhzangy R, et al
    Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents.
    PLoS One. 2021;16:e0254595.
    >> Share

  138. TRAVIS J, Harris S, Fadel T, Webb G, et al
    Identifying the determinants of COVID-19 preventative behaviors and vaccine intentions among South Carolina residents.
    PLoS One. 2021;16:e0256178.
    >> Share

  139. KRICORIAN K, Turner K
    COVID-19 Vaccine Acceptance and Beliefs among Black and Hispanic Americans.
    PLoS One. 2021;16:e0256122.
    >> Share

  140. KALAM MA, Davis TP Jr, Shano S, Uddin MN, et al
    Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions.
    PLoS One. 2021;16:e0256496.
    >> Share

  141. ALI RN, Rubin H, Sarkar S
    Countering the potential re-emergence of a deadly infectious disease-Information warfare, identifying strategic threats, launching countermeasures.
    PLoS One. 2021;16:e0256014.
    >> Share

  142. SALING LL, Mallal D, Scholer F, Skelton R, et al
    No one is immune to misinformation: An investigation of misinformation sharing by subscribers to a fact-checking newsletter.
    PLoS One. 2021;16:e0255702.
    >> Share

  143. ANGELO AT, Alemayehu DS, Dachew AM
    Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021.
    PLoS One. 2021;16:e0257109.
    >> Share

  144. SUNOHARA S, Asakura T, Kimura T, Ozawa S, et al
    Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan.
    PLoS One. 2021;16:e0257107.
    >> Share

  145. KULKARNI R, Chen WC, Lee Y, Kao CF, et al
    Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.
    PLoS One. 2021;16:e0257191.
    >> Share

  146. MAHMUD S, Mohsin M, Khan IA, Mian AU, et al
    Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh.
    PLoS One. 2021;16:e0257096.
    >> Share

  147. WISNEWSKI AV, Redlich CA, Liu J, Kamath K, et al
    Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines.
    PLoS One. 2021;16:e0252849.
    >> Share

  148. PEREZ-ARCE F, Angrisani M, Bennett D, Darling J, et al
    COVID-19 vaccines and mental distress.
    PLoS One. 2021;16:e0256406.
    >> Share

  149. SKLAR MJ, Maiolatesi S, Patterson N, Sedegah M, et al
    A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naive adults.
    PLoS One. 2021;16:e0256980.
    >> Share

  150. MALIK A, Malik J, Ishaq U
    Acceptance of COVID-19 vaccine in Pakistan among health care workers.
    PLoS One. 2021;16:e0257237.
    >> Share

  151. DERUELLE P, Couffignal C, Sibiude J, Vivanti AJ, et al
    Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
    PLoS One. 2021;16:e0256080.
    >> Share

  152. LIMOTHAI U, Tachaboon S, Dinhuzen J, Hunsawong T, et al
    Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area.
    PLoS One. 2021;16:e0257182.
    >> Share

  153. MENA G, Blanco B, Casas I, Huertas A, et al
    Attitudes of Spanish hospital staff towards COVID-19 vaccination and vaccination rates.
    PLoS One. 2021;16:e0257002.
    >> Share

  154. PRAVEEN C, Bhatia SS, Alaniz RC, Droleskey RE, et al
    Assessment of microbiological correlates and immunostimulatory potential of electron beam inactivated metabolically active yet non culturable (MAyNC) Salmonella Typhimurium.
    PLoS One. 2021;16:e0243417.
    >> Share

    January 2020
  155. VAN DER LINDEN M, Imohl M, Perniciaro S
    Correction: Limited indirect effects of an infant pneumococcal vaccination program in an aging population.
    PLoS One. 2020;15:e0228126.
    >> Share

  156. PATIC A, Strbac M, Petrovic V, Milosevic V, et al
    Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.
    PLoS One. 2020;15:e0227413.
    >> Share

  157. LU C, Song G, Beale K, Yan J, et al
    Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines.
    PLoS One. 2020;15:e0216260.
    >> Share

  158. MUPERE E, Babikako HM, Okaba-Kayom V, Mutyaba RB, et al
    Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda.
    PLoS One. 2020;15:e0218239.
    >> Share

  159. TOBIN GJ, Tobin JK, Gaidamakova EK, Wiggins TJ, et al
    A novel gamma radiation-inactivated sabin-based polio vaccine.
    PLoS One. 2020;15:e0228006.
    >> Share

  160. ZHAO LP, Fiore-Gartland A, Carpp LN, Cohen KW, et al
    Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.
    PLoS One. 2020;15:e0226803.
    >> Share

  161. FELDMAN C, Dlamini SK, Madhi SA, Meiring S, et al
    The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults.
    PLoS One. 2020;15:e0227945.
    >> Share

  162. FRIEDRICH F, Valadao MC, Brum M, Comaru T, et al
    Impact of maternal dTpa vaccination on the incidence of pertussis in young infants.
    PLoS One. 2020;15:e0228022.
    >> Share

  163. DUFOUR C, Fournier V, Giovenazzo P
    The impact of lowbush blueberry (Vaccinium angustifolium Ait.) and cranberry (Vaccinium macrocarpon Ait.) pollination on honey bee (Apis mellifera L.) colony health status.
    PLoS One. 2020;15:e0227970.
    >> Share

  164. NAIDU SK, Nabi R, Cheemarla NR, Stanfield BA, et al
    Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis.
    PLoS One. 2020;15:e0228252.
    >> Share

  165. DEBELLUT F, Jaber S, Bouzya Y, Sabbah J, et al
    Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
    PLoS One. 2020;15:e0228506.
    >> Share

  166. NONGNUCH A, Ngampongpan W, Srichatrapimuk S, Wongsa A, et al
    Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.
    PLoS One. 2020;15:e0227719.
    >> Share

  167. AI CE, Steele M, Lopman B
    Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study.
    PLoS One. 2020;15:e0228942.
    >> Share

  168. BAQUI AH, McCollum ED, Mahmud A, Roy A, et al
    Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh.
    PLoS One. 2020;15:e0228799.
    >> Share

  169. JANMOHAMMADI A, Sheikhi N, Nazarpak HH, Nikbakht Brujeni G, et al
    Effects of vaccination on acute-phase protein response in broiler chicken.
    PLoS One. 2020;15:e0229009.
    >> Share

  170. LIU X, Liang B, Liu X, Amaro-Carambot E, et al
    Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates.
    PLoS One. 2020;15:e0228572.
    >> Share

  171. LI XH, Vance GM, Cartwright J, Cao JP, et al
    Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs.
    PLoS One. 2020;15:e0229542.
    >> Share

  172. HU W, He M, Li L
    HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
    PLoS One. 2020;15:e0229327.
    >> Share

  173. KLEIN NP, Fireman B, Goddard K, Zerbo O, et al
    Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season.
    PLoS One. 2020;15:e0229279.
    >> Share

  174. MILHAU N, Almouazen E, Bouteille S, Hellel-Bourtal I, et al
    In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus.
    PLoS One. 2020;15:e0229121.
    >> Share

  175. MUNUSAMY PONNAN S, Hayes P, Fernandez N, Thiruvengadam K, et al
    Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India.
    PLoS One. 2020;15:e0229461.
    >> Share

  176. SARLI M, Novoa MB, Mazzucco MN, Signorini ML, et al
    A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
    PLoS One. 2020;15:e0229301.
    >> Share

  177. VIRNIK K, Rosati M, Medvedev A, Scanlan A, et al
    Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
    PLoS One. 2020;15:e0228163.
    >> Share

  178. JIMENEZ AV, Mesoudi A, Tehrani JJ
    No evidence that omission and confirmation biases affect the perception and recall of vaccine-related information.
    PLoS One. 2020;15:e0228898.
    >> Share

  179. FAKHRI O, Devlin JM, Browning GF, Vaz PK, et al
    Genomic recombination between infectious laryngotracheitis vaccine strains occurs under a broad range of infection conditions in vitro and in ovo.
    PLoS One. 2020;15:e0229082.
    >> Share

  180. CHAPARRO RM, Rodriguez B, Maza Y, Moyano D, et al
    Factors associated with hindering the acceptance of HPV vaccination among caregivers - A cross-sectional study in Argentina.
    PLoS One. 2020;15:e0229793.
    >> Share

  181. JANMOHAMMADI A, Sheikhi N, Nazarpak HH, Nikbakht Brujeni G, et al
    Correction: Effects of vaccination on acute-phase protein response in broiler chicken.
    PLoS One. 2020;15:e0230949.
    >> Share

  182. CHIRKOVA T, Ha B, Rimawi BH, Oomens AGP, et al
    In vitro model for the assessment of human immune responses to subunit RSV vaccines.
    PLoS One. 2020;15:e0229660.
    >> Share

  183. COSTA AS, Gomes JM, Germani ACCG, da Silva MR, et al
    Knowledge gaps and acquisition about HPV and its vaccine among Brazilian medical students.
    PLoS One. 2020;15:e0230058.
    >> Share

  184. HJALMARSDOTTIR MA, Haraldsson G, Quirk SJ, Haraldsson A, et al
    Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland.
    PLoS One. 2020;15:e0230332.
    >> Share

  185. ZHANG J, He J, Li J, Zhou Q, et al
    The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis.
    PLoS One. 2020;15:e0230381.
    >> Share

  186. HAO S, Wang C, Liu S, He J, et al
    HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.
    PLoS One. 2020;15:e0230640.
    >> Share

  187. OGAWA T, Inoue T, Kasahara K, Konishi M, et al
    Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    PLoS One. 2020;15:e0230329.
    >> Share

  188. LAPUENTE D, Stab V, Storcksdieck Genannt Bonsmann M, Maaske A, et al
    Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine.
    PLoS One. 2020;15:e0231138.
    >> Share

  189. O'CONNELL CM, Jasperse B, Hagen CJ, Titong A, et al
    Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
    PLoS One. 2020;15:e0230711.
    >> Share

  190. LI AJ, Tabu C, Shendale S, Okoth PO, et al
    Qualitative insights into reasons for missed opportunities for vaccination in Kenyan health facilities.
    PLoS One. 2020;15:e0230783.
    >> Share

  191. SCHRIJVERS-GONLAG M, Skarpe C, Andreassen HP
    Influence of light availability and soil productivity on insect herbivory on bilberry (Vaccinium myrtillus L.) leaves following mammalian herbivory.
    PLoS One. 2020;15:e0230509.
    >> Share

  192. LAURETTI-FERREIRA F, Silva PLD, Alcantara NM, Silva BF, et al
    New strategies for Leptospira vaccine development based on LPS removal.
    PLoS One. 2020;15:e0230460.
    >> Share

  193. TUCKERMAN J, Crawford NW, Marshall HS
    Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination.
    PLoS One. 2020;15:e0230425.
    >> Share

  194. BAHEMUKA UM, Abaasa A, Seeley J, Byaruhanga M, et al
    Feasibility of establishing an HIV vaccine preparedness cohort in a population of the Uganda Police Force: Lessons learnt from a prospective study.
    PLoS One. 2020;15:e0231640.
    >> Share

  195. LEUKER C, Samartzidis L, Hertwig R, Pleskac TJ, et al
    When money talks: Judging risk and coercion in high-paying clinical trials.
    PLoS One. 2020;15:e0227898.
    >> Share

  196. ACEVEDO-VILLANUEVA KY, Lester B, Renu S, Han Y, et al
    Efficacy of chitosan-based nanoparticle vaccine administered to broiler birds challenged with Salmonella.
    PLoS One. 2020;15:e0231998.
    >> Share

  197. LEE MF, Chen YH, Song PP, Lin TM, et al
    Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy.
    PLoS One. 2020;15:e0232042.
    >> Share

  198. ADAM A, Fusheini A
    Knowledge, risk of infection, and vaccination status of hepatitis B virus among rural high school students in Nanumba North and South Districts of Ghana.
    PLoS One. 2020;15:e0231930.
    >> Share

  199. OPANDA S, Bulimo W, Gachara G, Ekuttan C, et al
    Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene.
    PLoS One. 2020;15:e0228029.
    >> Share

  200. STEFANOFF P, Sobierajski T, Bulinska-Stangrecka H, Augustynowicz E, et al
    Exploring factors improving support for vaccinations among Polish primary care physicians.
    PLoS One. 2020;15:e0232722.
    >> Share

  201. SARKER AR, Islam Z, Sultana M, Sheikh N, et al
    Willingness to pay for oral cholera vaccines in urban Bangladesh.
    PLoS One. 2020;15:e0232600.
    >> Share

  202. PARZYCH EM, Miura K, Long CA, Burns JM Jr, et al
    Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
    PLoS One. 2020;15:e0232355.
    >> Share

  203. POTLURI R, Kumar A, Maheshwari V, Smith C, et al
    Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis.
    PLoS One. 2020;15:e0230406.
    >> Share

  204. GODFREY O, Zhang W, Amponsem-Boateng C, Bonney Oppong T, et al
    Evidence of rotavirus vaccine impact in sub-Saharan Africa: Systematic review and meta-analysis.
    PLoS One. 2020;15:e0232113.
    >> Share

  205. RIMAL S, Ojha KC, Chaisowwong W, Shah Y, et al
    Detection of virus-neutralising antibodies and associated factors against rabies in the vaccinated household dogs of Kathmandu Valley, Nepal.
    PLoS One. 2020;15:e0231967.
    >> Share

  206. RYYTI R, Hamalainen M, Peltola R, Moilanen E, et al
    Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation on metabolic and inflammatory adverse effects induced by high-fat diet in a mouse model of obesity.
    PLoS One. 2020;15:e0232605.
    >> Share

  207. CUMMINGS CL, Kong WY, Orminski J
    A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore.
    PLoS One. 2020;15:e0232472.
    >> Share

  208. MANSILLA FC, Turco CS, Miraglia MC, Bessone FA, et al
    The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine.
    PLoS One. 2020;15:e0232782.
    >> Share

  209. BENNETT DE, Meyler KL, Cafferkey MT, Cunney RJ, et al
    Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.
    PLoS One. 2020;15:e0228629.
    >> Share

  210. LIM W, Zhang P
    Herd immunity and a vaccination game: An experimental study.
    PLoS One. 2020;15:e0232652.
    >> Share

  211. ITO H, Nishimura H, Kisu T, Hagiwara H, et al
    Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.
    PLoS One. 2020;15:e0233001.
    >> Share

  212. SPRYGIN A, Pestova Y, Bjadovskaya O, Prutnikov P, et al
    Evidence of recombination of vaccine strains of lumpy skin disease virus with field strains, causing disease.
    PLoS One. 2020;15:e0232584.
    >> Share

  213. NAMAKULA R, de Bree LCJ, A Tvedt TH, Netea MG, et al
    Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and beta-glucan.
    PLoS One. 2020;15:e0229287.
    >> Share

  214. CASTRO JT, Oliveira GS, Nishigasako MA, Debrie AS, et al
    Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
    PLoS One. 2020;15:e0228055.
    >> Share

  215. CREPEY P, Redondo E, Diez-Domingo J, Ortiz de Lejarazu R, et al
    From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
    PLoS One. 2020;15:e0233526.
    >> Share

  216. MUNGWIRA RG, Guillard C, Saldana A, Okabe N, et al
    Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries.
    PLoS One. 2020;15:e0233334.
    >> Share

  217. CHANGOLKAR S, Rewley J, Balachandran M, Rareshide CAL, et al
    Phenotyping physician practice patterns and associations with response to a nudge in the electronic health record for influenza vaccination: A quasi-experimental study.
    PLoS One. 2020;15:e0232895.
    >> Share

  218. MBOUMBA BOUASSA RS, Pere H, Gubavu C, Prazuck T, et al
    Serum and cervicovaginal IgG immune responses against alpha7 and alpha9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.
    PLoS One. 2020;15:e0233084.
    >> Share

  219. SANCHEZ JN, Hudgens BR
    Vaccination and monitoring strategies for epidemic prevention and detection in the Channel Island fox (Urocyon littoralis).
    PLoS One. 2020;15:e0232705.
    >> Share

  220. SARKER AR, Sultana M
    Cost-effective analysis of childhood malaria vaccination in endemic hotspots of Bangladesh.
    PLoS One. 2020;15:e0233902.
    >> Share

  221. LI SW, Wright M, Healey JF, Hutchinson JM, et al
    Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.
    PLoS One. 2020;15:e0233866.
    >> Share

  222. ANDERSON JD 4TH, Pecenka CJ, Bagamian KH, Rheingans RD, et al
    Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
    PLoS One. 2020;15:e0232941.
    >> Share

  223. MPENDO J, Mutua G, Nanvubya A, Anzala O, et al
    Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
    PLoS One. 2020;15:e0233151.
    >> Share

  224. BASAK S, Kang HJ, Lee SH, Chu KB, et al
    Influenza vaccine efficacy induced by orally administered recombinant baculoviruses.
    PLoS One. 2020;15:e0233520.
    >> Share

  225. LEITE JA, Resende P, Araya JL, Barrera GB, et al
    Genetic evolution of influenza viruses among selected countries in Latin America, 2017-2018.
    PLoS One. 2020;15:e0227962.
    >> Share

  226. TUCCI P, Portela M, Chetto CR, Gonzalez-Sapienza G, et al
    Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate.
    PLoS One. 2020;15:e0221837.
    >> Share

  227. LUDWIG G, Garcia-Garcia S, Lanaspa M, Ciruela P, et al
    Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain.
    PLoS One. 2020;15:e0228612.
    >> Share

  228. MAHUMUD RA, Alam K, Keramat SA, Ormsby GM, et al
    Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
    PLoS One. 2020;15:e0233499.
    >> Share

  229. ARCHER RA, Kapoor R, Isaranuwatchai W, Teerawattananon Y, et al
    'It takes two to tango': Bridging the gap between country need and vaccine product innovation.
    PLoS One. 2020;15:e0233950.
    >> Share

  230. CARPP LN, Fong Y, Bonaparte M, Moodie Z, et al
    Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.
    PLoS One. 2020;15:e0234236.
    >> Share

  231. BROWNSTONE S, Connor A, Stein D
    Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake.
    PLoS One. 2020;15:e0233149.
    >> Share

  232. BLESER WK, Salmon DA, Miranda PY
    A hidden vulnerable population: Young children up-to-date on vaccine series recommendations except influenza vaccines.
    PLoS One. 2020;15:e0234466.
    >> Share

  233. OKOLI GN, Lam OLT, Racovitan F, Reddy VK, et al
    Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors.
    PLoS One. 2020;15:e0234702.
    >> Share

  234. SETIAWAN D, Andrijono, Hadinegoro SR, Meyta H, et al
    Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
    PLoS One. 2020;15:e0230359.
    >> Share

  235. JOBLING MG, Poole ST, Rasulova-Lewis F, O'Dowd A, et al
    Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera.
    PLoS One. 2020;15:e0230138.
    >> Share

  236. BUCHINSKY FJ, Ruszkay N, Valentino W, Derkay CS, et al
    In RRP, serologic response to HPV is frequently absent and slow to develop.
    PLoS One. 2020;15:e0230106.
    >> Share

  237. BWALYA P, Hang'ombe BM, Gamil AA, Munang'andu HM, et al
    A whole-cell Lactococcus garvieae autovaccine protects Nile tilapia against infection.
    PLoS One. 2020;15:e0230739.
    >> Share

  238. KILICH E, Dada S, Francis MR, Tazare J, et al
    Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0234827.
    >> Share

  239. SSEKAMATTE T, Mukama T, Kibira SPS, Ndejjo R, et al
    Hepatitis B screening and vaccination status of healthcare providers in Wakiso district, Uganda.
    PLoS One. 2020;15:e0235470.
    >> Share

  240. CHOJNACKY M, Rodriguez AL
    Effect of thermal ballast loading on temperature stability of domestic refrigerators used for vaccine storage.
    PLoS One. 2020;15:e0235777.
    >> Share

  241. DUMAS EK, Demiraslan H, Ingram RJ, Sparks RM, et al
    Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
    PLoS One. 2020;15:e0230782.
    >> Share

  242. SONG D, Qi F, Liu S, Tang Z, et al
    The adoptive transfer of BCG-induced T lymphocytes contributes to hippocampal cell proliferation and tempers anxiety-like behavior in immune deficient mice.
    PLoS One. 2020;15:e0225874.
    >> Share

  243. NEAL EFG, Nguyen CD, Ratu FT, Dunne EM, et al
    Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys.
    PLoS One. 2020;15:e0231041.
    >> Share

  244. KEAY S, Poljak Z, Klapwyk M, O'Connor A, et al
    Influenza A virus vaccine research conducted in swine from 1990 to May 2018: A scoping review.
    PLoS One. 2020;15:e0236062.
    >> Share

  245. BROWNSTONE S, Connor A, Stein D
    Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake.
    PLoS One. 2020;15:e0236542.
    >> Share

  246. HOSKING K, Stewart G, Mobsby M, Skov S, et al
    Data linkage and computerised algorithmic coding to enhance individual clinical care for Aboriginal people living with chronic hepatitis B in the Northern Territory of Australia - Is it feasible?
    PLoS One. 2020;15:e0232207.
    >> Share

  247. BARTOLO S, Mancel O, Deliege E, Carpentier S, et al
    Determinants of pregnant women's knowledge about influenza and the influenza vaccine: A large, single-centre cohort study.
    PLoS One. 2020;15:e0236793.
    >> Share

  248. SOVERI A, Karlsson LC, Maki O, Antfolk J, et al
    Trait reactance and trust in doctors as predictors of vaccination behavior, vaccine attitudes, and use of complementary and alternative medicine in parents of young children.
    PLoS One. 2020;15:e0236527.
    >> Share

  249. MUKANDAVIRE Z, Nyabadza F, Malunguza NJ, Cuadros DF, et al
    Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios.
    PLoS One. 2020;15:e0236003.
    >> Share

  250. BAKER L, Matthiopoulos J, Muller T, Freuling C, et al
    Local rabies transmission and regional spatial coupling in European foxes.
    PLoS One. 2020;15:e0220592.
    >> Share

  251. WU Q, Jia M, Chen H, Zhang S, et al
    The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: A retrospective case series study.
    PLoS One. 2020;15:e0232129.
    >> Share

  252. PIRALAM B, Prosperi C, Thamthitiwat S, Bunthi C, et al
    Pneumococcal colonization prevalence and density among Thai children with severe pneumonia and community controls.
    PLoS One. 2020;15:e0232151.
    >> Share

  253. ECKSTEIN C, Mol JPS, Costa FB, Nunes PP, et al
    Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs.
    PLoS One. 2020;15:e0231893.
    >> Share

  254. SABAHELZAIN MM, Dube E, Moukhyer M, Larson HJ, et al
    Psychometric properties of the adapted measles vaccine hesitancy scale in Sudan.
    PLoS One. 2020;15:e0237171.
    >> Share

  255. RUNGROJCHAROENKIT K, Sunintaboon P, Ellison D, Macareo L, et al
    Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study.
    PLoS One. 2020;15:e0237218.
    >> Share

  256. NIKI M, Yoshiyama T, Nagai H, Miyamoto Y, et al
    Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development.
    PLoS One. 2020;15:e0237062.
    >> Share

  257. CABEZAS C, Trujillo O, Balbuena J, Peceros FM, et al
    Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.
    PLoS One. 2020;15:e0236993.
    >> Share

  258. SARKAR M, Saha S
    Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
    PLoS One. 2020;15:e0237300.
    >> Share

  259. FILICE E, Dube E, Graham JE, MacDonald NE, et al
    Vaccination discourses among chiropractors, naturopaths and homeopaths: A qualitative content analysis of academic literature and Canadian organizational webpages.
    PLoS One. 2020;15:e0236691.
    >> Share

  260. DE VILLIERS MJ, Gamkrelidze I, Hallett TB, Nayagam S, et al
    Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models.
    PLoS One. 2020;15:e0237525.
    >> Share

  261. BARUTI K, Lentz K, Anderson M, Ajibola G, et al
    Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
    PLoS One. 2020;15:e0237252.
    >> Share

  262. AALEMI AK, Shahpar K, Mubarak MY
    Factors influencing vaccination coverage among children age 12-23 months in Afghanistan: Analysis of the 2015 Demographic and Health Survey.
    PLoS One. 2020;15:e0236955.
    >> Share

  263. BARAL R, Fleming J, Khan S, Higgins D, et al
    Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage.
    PLoS One. 2020;15:e0237718.
    >> Share

  264. LI AJ, Tabu C, Shendale S, Sergon K, et al
    Assessment of missed opportunities for vaccination in Kenyan health facilities, 2016.
    PLoS One. 2020;15:e0237913.
    >> Share

  265. PARKINSON LV, Mulder CPH
    Patterns of pollen and resource limitation of fruit production in Vaccinium uliginosum and V. vitis-idaea in Interior Alaska.
    PLoS One. 2020;15:e0224056.
    >> Share

  266. HASAN M, Azim KF, Imran MAS, Chowdhury IM, et al
    Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach.
    PLoS One. 2020;15:e0237181.
    >> Share

  267. URABE CT, Tanaka G, Oshima T, Maruyama A, et al
    Comparing catch-up vaccination programs based on analysis of 2012-13 rubella outbreak in Kawasaki City, Japan.
    PLoS One. 2020;15:e0237312.
    >> Share

  268. FISHER BS, Dambrauskas N, Trakhimets O, Andrade DV, et al
    Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates.
    PLoS One. 2020;15:e0233577.
    >> Share

  269. CHO HK, Hwang SH, Nam HN, Han K, et al
    Incidence of intussusception before and after the introduction of rotavirus vaccine in Korea.
    PLoS One. 2020;15:e0238185.
    >> Share

  270. ESCHLE S, Hartmann K, Rieger A, Fischer S, et al
    Canine vaccination in Germany: A survey of owner attitudes and compliance.
    PLoS One. 2020;15:e0238371.
    >> Share

  271. ASHHAB AA, Rodin H, Campos M, Abu-Sulb A, et al
    Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection.
    PLoS One. 2020;15:e0237398.
    >> Share

  272. OBERLANDER B, Failing K, Jungst CM, Neuhaus N, et al
    Evaluation of Newcastle Disease antibody titers in backyard poultry in Germany with a vaccination interval of twelve weeks.
    PLoS One. 2020;15:e0238068.
    >> Share

  273. MUTISYA EM, Mutua G, Nyasani D, Nduta H, et al
    Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
    PLoS One. 2020;15:e0238028.
    >> Share

  274. ZEDDEMAN A, van Schuppen E, Kok KE, van Gent M, et al
    Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site.
    PLoS One. 2020;15:e0237394.
    >> Share

  275. ROCKLIFFE L, Stearns S, Forster AS
    A qualitative exploration of using financial incentives to improve vaccination uptake via consent form return in female adolescents in London.
    PLoS One. 2020;15:e0237805.
    >> Share

  276. ABESIG J, Chen Y, Wang H, Sompo FM, et al
    Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0234348.
    >> Share

  277. AKAMATSU MA, Sakihara VA, Carvalho BP, de Paiva Abrantes A, et al
    Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in Brazil.
    PLoS One. 2020;15:e0233632.
    >> Share

  278. REUBEN R, Aitken D, Freedman JL, Einstein G, et al
    Mistrust of the medical profession and higher disgust sensitivity predict parental vaccine hesitancy.
    PLoS One. 2020;15:e0237755.
    >> Share

  279. ZHAO XN, Zhang HJ, Li D, Zhou JN, et al
    Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018.
    PLoS One. 2020;15:e0234869.
    >> Share

  280. SWAIN JK, Carpio Y, Johansen LH, Velazquez J, et al
    Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.).
    PLoS One. 2020;15:e0239827.
    >> Share

  281. JEMBERU WT, Molla W, Dagnew T, Rushton J, et al
    Farmers' willingness to pay for foot and mouth disease vaccine in different cattle production systems in Amhara region of Ethiopia.
    PLoS One. 2020;15:e0239829.
    >> Share

  282. BUDU E, Darteh EKM, Ahinkorah BO, Seidu AA, et al
    Trend and determinants of complete vaccination coverage among children aged 12-23 months in Ghana: Analysis of data from the 1998 to 2014 Ghana Demographic and Health Surveys.
    PLoS One. 2020;15:e0239754.
    >> Share

  283. KAMEI K, Miyairi I, Ishikura K, Ogura M, et al
    Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents.
    PLoS One. 2020;15:e0240217.
    >> Share

  284. SCHMITT-VAN DE LEEMPUT E, Metcalfe LVA, Caldow G, Walz PH, et al
    Comparison of milk production of dairy cows vaccinated with a live double deleted BVDV vaccine and non-vaccinated dairy cows cohabitating in commercial herds endemically infected with BVD virus.
    PLoS One. 2020;15:e0240113.
    >> Share

  285. VADLAMUDI NK, Patrick DM, Hoang L, Sadarangani M, et al
    Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study.
    PLoS One. 2020;15:e0239848.
    >> Share

  286. CHUNG GS, Hutton DW
    Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry.
    PLoS One. 2020;15:e0239926.
    >> Share

  287. NOWAK SA, Chen C, Parker AM, Gidengil CA, et al
    Comparing covariation among vaccine hesitancy and broader beliefs within Twitter and survey data.
    PLoS One. 2020;15:e0239826.
    >> Share

  288. HUGHES HE, Elliot AJ, Hughes TC, Hungerford D, et al
    Using emergency department syndromic surveillance to investigate the impact of a national vaccination program: A retrospective observational study.
    PLoS One. 2020;15:e0240021.
    >> Share

  289. KUMAR A, Misra S, Verma V, Vishwakarma RK, et al
    Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.
    PLoS One. 2020;15:e0240710.
    >> Share

  290. HUON JF, Gregoire A, Meireles A, Lefebvre M, et al
    Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
    PLoS One. 2020;15:e0234693.
    >> Share

  291. LI J, Yu W, Zhao Z, Zhang L, et al
    Measles vaccination among children in border areas of Yunnan Province, Southwest China.
    PLoS One. 2020;15:e0240733.
    >> Share

  292. FOIS A, Boucher-Lafleur AM, Thompson Legault J, Renaud C, et al
    Humoral responses to the measles, mumps and rubella vaccine are impaired in Leigh Syndrome French Canadian patients.
    PLoS One. 2020;15:e0239860.
    >> Share

  293. BONNEVIE E, Rosenberg SD, Kummeth C, Goldbarg J, et al
    Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine.
    PLoS One. 2020;15:e0240828.
    >> Share

  294. AGYEI-BAFFOUR P, Asare M, Lanning B, Koranteng A, et al
    Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers: A qualitative study based on multi-theory model.
    PLoS One. 2020;15:e0240657.
    >> Share

  295. DEGAREGE A, Krupp K, Srinivas V, Ibrahimou B, et al
    Structural equation modeling to detect correlates of childhood vaccination: A moderated mediation analysis.
    PLoS One. 2020;15:e0240749.
    >> Share

  296. COHEN ND, Cywes-Bentley C, Kahn SM, Bordin AI, et al
    Vaccination of yearling horses against poly-N-acetyl glucosamine fails to protect against infection with Streptococcus equi subspecies equi.
    PLoS One. 2020;15:e0240479.
    >> Share

  297. KHAIRKHAH N, Aghasadeghi MR, Namvar A, Bolhassani A, et al
    Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
    PLoS One. 2020;15:e0240577.
    >> Share

  298. ANDERSON MS, Niemuth NA, Sabourin CL, Badorrek CS, et al
    Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
    PLoS One. 2020;15:e0238196.
    >> Share

  299. TSAI MH, Liao SL, Chiu CY, Shih HJ, et al
    Longitudinal investigation of nasopharyngeal pneumococcal carriage in early childhood: The PATCH birth cohort study.
    PLoS One. 2020;15:e0237871.
    >> Share

  300. KANDEIL A, Gomaa MR, El Taweel A, Mostafa A, et al
    Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.
    PLoS One. 2020;15:e0241471.
    >> Share

  301. AWOKE N, Mulgeta H, Lolaso T, Tekalign T, et al
    Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241226.
    >> Share

  302. SZIGETI R, Kellermayer D, Trakimas G, Kellermayer R, et al
    BCG epidemiology supports its protection against COVID-19? A word of caution.
    PLoS One. 2020;15:e0240203.
    >> Share

  303. NOEL G, Badmasti F, Nikbin VS, Zahraei SM, et al
    Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran.
    PLoS One. 2020;15:e0238398.
    >> Share

  304. GURNANI V, Singh P, Haldar P, Aggarwal MK, et al
    Programmatic assessment of electronic Vaccine Intelligence Network (eVIN).
    PLoS One. 2020;15:e0241369.
    >> Share

  305. VILCHES TN, Shoukat A, Ferreira CP, Moghadas SM, et al
    Projecting influenza vaccine effectiveness: A simulation study.
    PLoS One. 2020;15:e0241549.
    >> Share

  306. WHITE ER, Hebert-Dufresne L
    State-level variation of initial COVID-19 dynamics in the United States.
    PLoS One. 2020;15:e0240648.
    >> Share

  307. ARAUJO LO, Nunes AMPB, Ferreira VM, Cardoso CW, et al
    Clinical and epidemiological features of pertussis in Salvador, Brazil, 2011-2016.
    PLoS One. 2020;15:e0238932.
    >> Share

  308. DE MUNTER AC, Ruijs WLM, Ruiter RAC, van Nimwegen DJJ, et al
    Decision-making on maternal pertussis vaccination among women in a vaccine-hesitant religious group: Stages and needs.
    PLoS One. 2020;15:e0242261.
    >> Share

  309. GOMES JM, Silva BM, Santos EFS, Kelly PJ, et al
    Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance.
    PLoS One. 2020;15:e0241674.
    >> Share

  310. SHAHZAMAL M, Mans B, Hoog F, Paini D, et al
    Vaccination strategies on dynamic networks with indirect transmission links and limited contact information.
    PLoS One. 2020;15:e0241612.
    >> Share

  311. CARANNANTE A, Fazio C, Neri A, Lista F, et al
    Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.
    PLoS One. 2020;15:e0241793.
    >> Share

  312. KAZIMBAYA KM, Chisenga CC, Simuyandi M, Phiri CM, et al
    In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
    PLoS One. 2020;15:e0240714.
    >> Share

  313. VEZINA B, Petit GA, Martin JL, Halili MA, et al
    Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets.
    PLoS One. 2020;15:e0241306.
    >> Share

  314. CASPE SG, Livingstone M, Frew D, Aitchison K, et al
    The 1B vaccine strain of Chlamydia abortus produces placental pathology indistinguishable from a wild type infection.
    PLoS One. 2020;15:e0242526.
    >> Share

  315. SHRESTHA DB, Khadka M, Khadka M, Subedi P, et al
    Hepatitis B vaccination status and knowledge, attitude, and practice regarding Hepatitis B among preclinical medical students of a medical college in Nepal.
    PLoS One. 2020;15:e0242658.
    >> Share

  316. BAYU H, Elias B, Abdisa S, Tune A, et al
    Post exposure prophylaxis coverage, vertical transmission and associated factors among hepatitis B exposed newborns delivered at Arsi zone health institutions, 2019.
    PLoS One. 2020;15:e0238987.
    >> Share

  317. HAVLICEK DF, Rosenberg JB, De BP, Hicks MJ, et al
    Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
    PLoS One. 2020;15:e0239780.
    >> Share

  318. GONZALEZ-BLOCK MA, Gutierrez-Calderon E, Pelcastre-Villafuerte BE, Arroyo-Laguna J, et al
    Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates.
    PLoS One. 2020;15:e0243833.
    >> Share

  319. WHANG YH, Kim SK, Yoon H, Choi SK, et al
    Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.
    PLoS One. 2020;15:e0243909.
    >> Share

  320. LUCIDARME J, Zhu B, Xu L, Bai X, et al
    Genomic analysis of the meningococcal ST-4821 complex-Western clade, potential sexual transmission and predicted antibiotic susceptibility and vaccine coverage.
    PLoS One. 2020;15:e0243426.
    >> Share

  321. KAJUNGU D, Muhoozi M, Stark J, Weibel D, et al
    Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approach.
    PLoS One. 2020;15:e0243834.
    >> Share

  322. NAGHIBI L, Yazdani M, Momtazi-Borojeni AA, Razazan A, et al
    Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
    PLoS One. 2020;15:e0243550.
    >> Share

  323. Expression of Concern: Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
    PLoS One. 2020;15:e0244011.
    >> Share

  324. HEFELE L, Syphan S, Xayavong D, Homsana A, et al
    Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
    PLoS One. 2020;15:e0242502.
    >> Share

  325. VEGA-POLO P, Cobo MM, Argudo A, Gutierrez B, et al
    Characterizing the genetic diversity of the Andean blueberry (Vaccinium floribundum Kunth.) across the Ecuadorian Highlands.
    PLoS One. 2020;15:e0243420.
    >> Share

  326. CHIMOYI L, Velen K, Churchyard GJ, Wallis R, et al
    An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19.
    PLoS One. 2020;15:e0243707.
    >> Share

  327. Retraction: Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.
    PLoS One. 2020;15:e0244074.
    >> Share

  328. CARCELEN AC, Hayford K, Moss WJ, Book C, et al
    How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia.
    PLoS One. 2020;15:e0240734.
    >> Share

  329. TAHIR UL QAMAR M, Rehman A, Tusleem K, Ashfaq UA, et al
    Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
    PLoS One. 2020;15:e0244176.
    >> Share

  330. AJIBOLA G, Bennett K, Powis KM, Hughes MD, et al
    Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
    PLoS One. 2020;15:e0244100.
    >> Share

  331. DE LEMOS APS, Sacchi CT, Goncalves CR, Camargo CH, et al
    Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
    PLoS One. 2020;15:e0243375.
    >> Share

  332. FUDOLIG M, Howard R
    The local stability of a modified multi-strain SIR model for emerging viral strains.
    PLoS One. 2020;15:e0243408.
    >> Share

  333. JIANG W, Pilkington EH, Kelly HG, Tan HX, et al
    Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem.
    PLoS One. 2020;15:e0241649.
    >> Share

  334. BELL S, Clarke R, Paterson P, Mounier-Jack S, et al
    Parents' and guardians' views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England.
    PLoS One. 2020;15:e0244049.
    >> Share

  335. BERRY DA, Berry S, Hale P, Isakov L, et al
    A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates.
    PLoS One. 2020;15:e0244418.
    >> Share

  336. BOZIO CH, Isenhour C, McNamara LA
    Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States.
    PLoS One. 2020;15:e0241989.
    >> Share

  337. DO PC, Nguyen TH, Vo UHM, Le L, et al
    iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus.
    PLoS One. 2020;15:e0239112.
    >> Share

  338. TALAAT KR, Porter CK, Jaep KM, Duplessis CA, et al
    Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
    PLoS One. 2020;15:e0239888.
    >> Share

  339. MENIKOU S, McArdle AJ, Li MS, Kaforou M, et al
    A proteomics-based method for identifying antigens within immune complexes.
    PLoS One. 2020;15:e0244157.
    >> Share

  340. MUWONGE R, Basu P, Gheit T, Anantharaman D, et al
    Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.
    PLoS One. 2020;15:e0244242.
    >> Share

    January 2019
  341. ZEBERTAVAGE L, Bambina S, Shugart J, Alice A, et al
    A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.
    PLoS One. 2019;14:e0209153.
    >> Share

  342. HODGINS B, Pillet S, Landry N, Ward BJ, et al
    A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities.
    PLoS One. 2019;14:e0210009.
    >> Share

  343. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0210081.
    >> Share

  344. PERNICIARO S, Imohl M, Fitzner C, van der Linden M, et al
    Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany.
    PLoS One. 2019;14:e0210278.
    >> Share

  345. LEE YY, Wang Z
    Facilitators and barriers for healthcare providers to recommend HPV vaccination to attendees of public sexually transmitted diseases clinics in Hong Kong, China.
    PLoS One. 2019;14:e0209942.
    >> Share

  346. ATCHESON E, Bauza K, Reyes-Sandoval A
    A probabilistic model of pre-erythrocytic malaria vaccine combination in mice.
    PLoS One. 2019;14:e0209028.
    >> Share

  347. NYARI S, Booth R, Quigley BL, Waugh CA, et al
    Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus).
    PLoS One. 2019;14:e0210245.
    >> Share

  348. YOU JHS, Ming WK, Tsang OT, Chan PK, et al
    Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults.
    PLoS One. 2019;14:e0210005.
    >> Share

  349. KISLAYA I, Rodrigues AP, Sousa-Uva M, Gomez V, et al
    Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
    PLoS One. 2019;14:e0209428.
    >> Share

  350. WORMSBECKER AE, Johnson C, Bourns L, Harris T, et al
    Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
    PLoS One. 2019;14:e0210833.
    >> Share

  351. BAHEMUKA UM, Abaasa A, Ruzagira E, Lindan C, et al
    Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda.
    PLoS One. 2019;14:e0198460.
    >> Share

  352. OGBUANU IU, Li AJ, Anya BM, Tamadji M, et al
    Can vaccination coverage be improved by reducing missed opportunities for vaccination? Findings from assessments in Chad and Malawi using the new WHO methodology.
    PLoS One. 2019;14:e0210648.
    >> Share

  353. ROSANOWSKI SM, Carpenter TE, Adamson D, Rogers CW, et al
    An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country.
    PLoS One. 2019;14:e0210885.
    >> Share

  354. PRIMO ME, Thompson CS, Valentini BS, Sarli M, et al
    Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle.
    PLoS One. 2019;14:e0211149.
    >> Share

  355. HOULE SKD, Eurich DT
    Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada.
    PLoS One. 2019;14:e0211006.
    >> Share

  356. CUI J, O'Connell CM, Costa A, Pan Y, et al
    A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0208801.
    >> Share

  357. ROCKSTROH JK, Asmuth D, Pantaleo G, Clotet B, et al
    Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
    PLoS One. 2019;14:e0210965.
    >> Share

  358. CASAL J, Saegerman C, Bertagnoli S, Meyer G, et al
    A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France.
    PLoS One. 2019;14:e0210317.
    >> Share

  359. ESPANA G, Hogea C, Guignard A, Ten Bosch QA, et al
    Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms.
    PLoS One. 2019;14:e0210041.
    >> Share

  360. YUN JW, Choi MJ, Shin GS, Lim JO, et al
    Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea.
    PLoS One. 2019;14:e0209643.
    >> Share

  361. MARTINEZ L, Milanic M, Malaina I, Alvarez C, et al
    Weighted lambda superstrings applied to vaccine design.
    PLoS One. 2019;14:e0211714.
    >> Share

  362. KIM HW, Lee HY, Kim SE, Ahn HY, et al
    Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea.
    PLoS One. 2019;14:e0211475.
    >> Share

  363. LEVY C, Varon E, Ouldali N, Wollner A, et al
    Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine.
    PLoS One. 2019;14:e0211712.
    >> Share

  364. CHAKRABARTI A, Grepin KA, Helleringer S
    The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
    PLoS One. 2019;14:e0212049.
    >> Share

  365. MEDISE BE, Soedjatmiko S, Rengganis I, Gunardi H, et al
    Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
    PLoS One. 2019;14:e0211784.
    >> Share

  366. WILDE S, Jiang Y, Tafoya AM, Horsman J, et al
    Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis.
    PLoS One. 2019;14:e0197721.
    >> Share

  367. CUI J, O'Connell CM, Costa A, Pan Y, et al
    Correction: A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0213091.
    >> Share

  368. REUSCHEL E, Jilg W, Seelbach-Goebel B, Deml L, et al
    Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
    PLoS One. 2019;14:e0212800.
    >> Share

  369. GUERRA-MAUPOME M, Vang DX, McGill JL
    Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    PLoS One. 2019;14:e0212751.
    >> Share

  370. ALCOLEA PJ, Alonso A, Esteban A, Peris P, et al
    IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.
    PLoS One. 2019;14:e0212136.
    >> Share

  371. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0212957.
    >> Share

  372. NGOCHO JS, Magoma B, Olomi GA, Mahande MJ, et al
    Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.
    PLoS One. 2019;14:e0212295.
    >> Share

  373. BOULTON ML, Carlson BF, Wagner AL, Porth JM, et al
    Vaccination timeliness among newborns and infants in Ethiopia.
    PLoS One. 2019;14:e0212408.
    >> Share

  374. TUMIOTTO C, Alves BM, Recordon-Pinson P, Jourdain M, et al
    Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
    PLoS One. 2019;14:e0212347.
    >> Share

  375. BACK YW, Choi S, Choi HG, Shin KW, et al
    Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    PLoS One. 2019;14:e0213536.
    >> Share

  376. KELLY JD, Worden L, Wannier SR, Hoff NA, et al
    Projections of Ebola outbreak size and duration with and without vaccine use in Equateur, Democratic Republic of Congo, as of May 27, 2018.
    PLoS One. 2019;14:e0213190.
    >> Share

  377. SRIVASTAV A, O'Halloran A, Lu PJ, Williams WW, et al
    Vaccination differences among U.S. adults by their self-identified sexual orientation, National Health Interview Survey, 2013-2015.
    PLoS One. 2019;14:e0213431.
    >> Share

  378. KIM HJ, Son HS, Lee SW, Yoon Y, et al
    Efficient expression of enterovirus 71 based on virus-like particles vaccine.
    PLoS One. 2019;14:e0210477.
    >> Share

  379. VAN DER WEELE P, Breeuwsma M, Donken R, van Logchem E, et al
    Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females.
    PLoS One. 2019;14:e0212927.
    >> Share

  380. DABRAL N, Burcham GN, Jain-Gupta N, Sriranganathan N, et al
    Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    PLoS One. 2019;14:e0213587.
    >> Share

  381. MOHAMMED H, McMillan M, Roberts CT, Marshall HS, et al
    A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.
    PLoS One. 2019;14:e0214538.
    >> Share

  382. THILAKARATHNE DS, Coppo MJC, Hartley CA, Diaz-Mendez A, et al
    Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    PLoS One. 2019;14:e0213866.
    >> Share

  383. MUNUSAMY PONNAN S, Pattabiram S, Thiruvengadam K, Goyal R, et al
    Induction and maintenance of bi-functional (IFN-gamma + IL-2+ and IL-2+ TNF-alpha+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2019;14:e0213911.
    >> Share

  384. MWANGOME M, Ngari M, Bwahere P, Kabore P, et al
    Anthropometry at birth and at age of routine vaccination to predict mortality in the first year of life: A birth cohort study in BukinaFaso.
    PLoS One. 2019;14:e0213523.
    >> Share

  385. BERNSTEIN DI, Cardin RD, Pullum DA, Bravo FJ, et al
    Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.
    PLoS One. 2019;14:e0213401.
    >> Share

  386. WIBABARA Y, Banura C, Kalyango J, Karamagi C, et al
    Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences.
    PLoS One. 2019;14:e0214732.
    >> Share

  387. MAENETJE P, Lindan C, Makkan H, Chetty-Makkan CM, et al
    HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa.
    PLoS One. 2019;14:e0214786.
    >> Share

  388. VUPPUTURI S, Rubenstein KB, Derus AJ, Loftus BC, et al
    Factors contributing to racial disparities in influenza vaccinations.
    PLoS One. 2019;14:e0213972.
    >> Share

  389. MESA KA, Yu B, Wrin T, Petropoulos CJ, et al
    Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
    PLoS One. 2019;14:e0213409.
    >> Share

  390. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey.
    PLoS One. 2019;14:e0215125.
    >> Share

  391. WILLIAMS LBA, Fry LM, Herndon DR, Franceschi V, et al
    A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    PLoS One. 2019;14:e0215605.
    >> Share

  392. MOONSAMY S, Suchard M, Madhi SA
    Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.
    PLoS One. 2019;14:e0215079.
    >> Share

  393. WILLIAMS GA, Koenen ME, Havenaar R, Wheeler P, et al
    Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.
    PLoS One. 2019;14:e0214859.
    >> Share

  394. ROWELL J, Lo CY, Price GE, Misplon JA, et al
    The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.
    PLoS One. 2019;14:e0215321.
    >> Share

  395. LOUBET P, Nguyen C, Burnet E, Launay O, et al
    Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives.
    PLoS One. 2019;14:e0215251.
    >> Share

  396. BERTOLDO G, Pesce A, Pepe A, Pelullo CP, et al
    Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy.
    PLoS One. 2019;14:e0215978.
    >> Share

  397. PEASAH SK, Meltzer MI, Vu M, Moulia DL, et al
    Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    PLoS One. 2019;14:e0213499.
    >> Share

  398. YUAN Q, Wang F, Zheng H, Zhang G, et al
    Hepatitis B vaccination coverage among health care workers in China.
    PLoS One. 2019;14:e0216598.
    >> Share

  399. MASONOU T, Hokey DA, Lahey T, Halliday A, et al
    CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
    PLoS One. 2019;14:e0217091.
    >> Share

  400. VERHEES RAF, Thijs C, Ambergen T, Dinant GJ, et al
    Influenza vaccination in the elderly: 25 years follow-up of a randomized controlled trial. No impact on long-term mortality.
    PLoS One. 2019;14:e0216983.
    >> Share

  401. SEGURA M, Lopez-Gigosos R, Mariscal-Lopez E, Gutierrez-Bedmar M, et al
    Trends in the travelers' demand for pre-travel medical advice at a Spanish International Vaccination Center between 2000 and 2017.
    PLoS One. 2019;14:e0217588.
    >> Share

  402. ALFONSO VH, Bratcher A, Ashbaugh H, Doshi R, et al
    Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo.
    PLoS One. 2019;14:e0217426.
    >> Share

  403. PILLET S, Couillard J, Trepanier S, Poulin JF, et al
    Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and >/=50 years old adults.
    PLoS One. 2019;14:e0216533.
    >> Share

  404. BIDDLECOME A, Habte HH, McGrath KM, Sambanthamoorthy S, et al
    Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles.
    PLoS One. 2019;14:e0215031.
    >> Share

  405. MBOUMBA BOUASSA RS, Nodjikouambaye ZA, Sadjoli D, Adawaye C, et al
    High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
    PLoS One. 2019;14:e0217486.
    >> Share

  406. KOS S, Lopes A, Preat V, Cemazar M, et al
    Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.
    PLoS One. 2019;14:e0217762.
    >> Share

  407. TEMBO T, Simuyandi M, Chiyenu K, Sharma A, et al
    Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
    PLoS One. 2019;14:e0215972.
    >> Share

  408. SAGIYEV Z, Berdibekov A, Bolger T, Merekenova A, et al
    Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015.
    PLoS One. 2019;14:e0218366.
    >> Share

  409. LUNA BM, Nielsen TB, Cheng B, Pantapalangkoor P, et al
    Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.
    PLoS One. 2019;14:e0217439.
    >> Share

  410. WANGMO K, Laven R, Cliquet F, Wasniewski M, et al
    Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan.
    PLoS One. 2019;14:e0209946.
    >> Share

  411. SABAHELZAIN MM, Moukhyer M, Dube E, Hardan A, et al
    Towards a further understanding of measles vaccine hesitancy in Khartoum state, Sudan: A qualitative study.
    PLoS One. 2019;14:e0213882.
    >> Share

  412. RAGHAVA MOHAN V, Raj S, Dhingra MS, Aloysia D'Cor N, et al
    Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
    PLoS One. 2019;14:e0218033.
    >> Share

  413. KANG HJ, Chu KB, Lee DH, Lee SH, et al
    Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs.
    PLoS One. 2019;14:e0216871.
    >> Share

  414. DESHEVA Y, Leontieva G, Kramskaya T, Grabovskaya KB, et al
    Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections.
    PLoS One. 2019;14:e0218544.
    >> Share

  415. Retraction: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    PLoS One. 2019;14:e0218050.
    >> Share

  416. WU HH, Chang YY, Kuo SC, Chen YT, et al
    Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study.
    PLoS One. 2019;14:e0219172.
    >> Share

  417. OBIRI-YEBOAH D, Awuku YA, Adjei G, Cudjoe O, et al
    Post Hepatitis B vaccination sero-conversion among health care workers in the Cape Coast Metropolis of Ghana.
    PLoS One. 2019;14:e0219148.
    >> Share

  418. STENZEL T, Dziewulska D, Smialek M, Tykalowski B, et al
    Comparison of the immune response to vaccination with pigeon circovirus recombinant capsid protein (PiCV rCP) in pigeons uninfected and subclinically infected with PiCV.
    PLoS One. 2019;14:e0219175.
    >> Share

  419. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental pneumococcal vaccine for mucosal immunization.
    PLoS One. 2019;14:e0218679.
    >> Share

  420. ADAMU AA, Uthman OA, Gadanya MA, Adetokunboh OO, et al
    A multilevel analysis of the determinants of missed opportunities for vaccination among children attending primary healthcare facilities in Kano, Nigeria: Findings from the pre-implementation phase of a collaborative quality improvement programme.
    PLoS One. 2019;14:e0218572.
    >> Share

  421. MIYASHITA Y, Ishikawa K, Fukushima Y, Kouwaki T, et al
    Immune-regulatory microRNA expression levels within circulating extracellular vesicles correspond with the appearance of local symptoms after seasonal flu vaccination.
    PLoS One. 2019;14:e0219510.
    >> Share

  422. KIM MH, Kim HJ, Chang J
    Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    PLoS One. 2019;14:e0220196.
    >> Share

  423. ALESSANDRINI V, Anselem O, Girault A, Mandelbrot L, et al
    Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?
    PLoS One. 2019;14:e0220705.
    >> Share

  424. BRICOUT H, Torcel-Pagnon L, Lecomte C, Almas MF, et al
    Determinants of shingles vaccine acceptance in the United Kingdom.
    PLoS One. 2019;14:e0220230.
    >> Share

  425. VAN DER LINDEN M, Imohl M, Perniciaro S
    Limited indirect effects of an infant pneumococcal vaccination program in an aging population.
    PLoS One. 2019;14:e0220453.
    >> Share

  426. ANDRESEN AMS, Lutfi E, Ruyter B, Berge G, et al
    Interaction between dietary fatty acids and genotype on immune response in Atlantic salmon (Salmo salar) after vaccination: A transcriptome study.
    PLoS One. 2019;14:e0219625.
    >> Share

  427. SCHMEDT N, Schiffner-Rohe J, Sprenger R, Walker J, et al
    Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.
    PLoS One. 2019;14:e0220848.
    >> Share

  428. BENNASRALLAH C, Kacem M, Dhouib W, Zemni I, et al
    BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0219991.
    >> Share

  429. CAMPBELL ZA, Thumbi SM, Marsh TL, Quinlan MB, et al
    Why isn't everyone using the thermotolerant vaccine? Preferences for Newcastle disease vaccines by chicken-owning households in Tanzania.
    PLoS One. 2019;14:e0220963.
    >> Share

  430. JEONG S, Jang EJ, Jo J, Jang S, et al
    Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis.
    PLoS One. 2019;14:e0220910.
    >> Share

  431. WOLFSON LJ, Daniels VJ, Pillsbury M, Kurugol Z, et al
    Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.
    PLoS One. 2019;14:e0220921.
    >> Share

  432. FRALEIGH NL, Oliva R, Lewicky JD, Martel AL, et al
    Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
    PLoS One. 2019;14:e0221708.
    >> Share

  433. DRURY RE, Pollard AJ, O'Connor D
    The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies.
    PLoS One. 2019;14:e0221143.
    >> Share

  434. MAREFIAW TA, Yenesew MA, Mihirete KM
    Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.
    PLoS One. 2019;14:e0218470.
    >> Share

  435. FERRERAS E, Matapo B, Chizema-Kawesha E, Chewe O, et al
    Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    PLoS One. 2019;14:e0219040.
    >> Share

  436. BITSOUNI V, Lycett S, Opriessnig T, Doeschl-Wilson A, et al
    Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs.
    PLoS One. 2019;14:e0220738.
    >> Share

  437. JUSTWAN F, Baumgaertner B, Carlisle JE, Carson E, et al
    The effect of trust and proximity on vaccine propensity.
    PLoS One. 2019;14:e0220658.
    >> Share

  438. NAKATUDDE I, Rujumba J, Namiiro F, Sam A, et al
    Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda.
    PLoS One. 2019;14:e0221902.
    >> Share

  439. KRAMSKAYA T, Leontieva G, Desheva Y, Grabovskaya K, et al
    Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice.
    PLoS One. 2019;14:e0222148.
    >> Share

  440. VON MOLLENDORF C, La Vincente S, Ulziibayar M, Suuri B, et al
    Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016.
    PLoS One. 2019;14:e0222423.
    >> Share

  441. CHAN JA, Wetzel D, Reiling L, Miura K, et al
    Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
    PLoS One. 2019;14:e0221733.
    >> Share

  442. ISLAM MA, Neuhoff C, Aqter Rony S, Grosse-Brinkhaus C, et al
    PBMCs transcriptome profiles identified breed-specific transcriptome signatures for PRRSV vaccination in German Landrace and Pietrain pigs.
    PLoS One. 2019;14:e0222513.
    >> Share

  443. BRAEYE T, Bauchau V, Sturkenboom M, Emborg HD, et al
    Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.
    PLoS One. 2019;14:e0222296.
    >> Share

  444. CARTER C, Houser KV, Yamshchikov GV, Bellamy AR, et al
    Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
    PLoS One. 2019;14:e0222178.
    >> Share

  445. MACICAME I, Bhatt N, Matavele Chissumba R, Eller LA, et al
    HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique.
    PLoS One. 2019;14:e0221682.
    >> Share

  446. SISTERE-ORO M, Lopez-Serrano S, Veljkovic V, Pina-Pedrero S, et al
    DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
    PLoS One. 2019;14:e0222201.
    >> Share

  447. DIAZ-GARCIA L, Rodriguez-Bonilla L, Phillips M, Lopez-Hernandez A, et al
    Comprehensive analysis of the internal structure and firmness in American cranberry (Vaccinium macrocarpon Ait.) fruit.
    PLoS One. 2019;14:e0222451.
    >> Share

  448. KRAFT C, Hennies R, Dreckmann K, Noguera M, et al
    Evaluation of PRRSv specific, maternally derived and induced immune response in Ingelvac PRRSFLEX EU vaccinated piglets in the presence of maternally transferred immunity.
    PLoS One. 2019;14:e0223060.
    >> Share

  449. MONAMELE CG, Munshili Njifon HL, Vernet MA, Njankouo MR, et al
    Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2019;14:e0210119.
    >> Share

  450. COETZER A, Gwenhure L, Makaya P, Markotter W, et al
    Epidemiological aspects of the persistent transmission of rabies during an outbreak (2010 - 2017) in Harare, Zimbabwe.
    PLoS One. 2019;14:e0210018.
    >> Share

  451. YOSHINO T, Miyazaki J, Kojima T, Kandori S, et al
    Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model.
    PLoS One. 2019;14:e0209196.
    >> Share

  452. Correction: BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0223903.
    >> Share

  453. ENERLY E, Flingtorp R, Christiansen IK, Campbell S, et al
    An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    PLoS One. 2019;14:e0223612.
    >> Share

  454. NAGANT C, Barbezange C, Dedeken L, Besse-Hammer T, et al
    Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.
    PLoS One. 2019;14:e0223991.
    >> Share

  455. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2019;14:e0223658.
    >> Share

  456. KATO H, Takayama-Ito M, Iizuka-Shiota I, Fukushi S, et al
    Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
    PLoS One. 2019;14:e0223684.
    >> Share

  457. AL-OMAR HA, Sherif HM, Mayet AY
    Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.
    PLoS One. 2019;14:e0223594.
    >> Share

  458. MARTINEZ-VEGA R, Jauneikaite E, Thoon KC, Chua HY, et al
    Risk factor profiles and clinical outcomes for children and adults with pneumococcal infections in Singapore: A need to expand vaccination policy?
    PLoS One. 2019;14:e0220951.
    >> Share

  459. STAUFT CB, Yang C, Coleman JR, Boltz D, et al
    Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
    PLoS One. 2019;14:e0223784.
    >> Share

  460. BRADHURST R, Garner G, East I, Death C, et al
    Management strategies for vaccinated animals after an outbreak of foot-and-mouth disease and the impact on return to trade.
    PLoS One. 2019;14:e0223518.
    >> Share

  461. WU CY, Yu SL, Chen YT, Chen YH, et al
    The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.
    PLoS One. 2019;14:e0210553.
    >> Share

  462. JIANG L, Tian X, Peng D, Zhang L, et al
    HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    PLoS One. 2019;14:e0210311.
    >> Share

  463. CLOTHIER HJ, Lawrie J, Russell MA, Kelly H, et al
    Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia.
    PLoS One. 2019;14:e0224702.
    >> Share

  464. KARLSSON LC, Lewandowsky S, Antfolk J, Salo P, et al
    The association between vaccination confidence, vaccination behavior, and willingness to recommend vaccines among Finnish healthcare workers.
    PLoS One. 2019;14:e0224330.
    >> Share

  465. HANSEN NS, Byberg S, Jacobsen LH, Bjerregaard-Andersen M, et al
    Correction: Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau.
    PLoS One. 2019;14:e0224782.
    >> Share

  466. CURRY JM, Besmer DM, Erick TK, Steuerwald N, et al
    Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.
    PLoS One. 2019;14:e0224309.
    >> Share

  467. LA TM, Choi EJ, Lee JB, Park SY, et al
    Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus.
    PLoS One. 2019;14:e0211158.
    >> Share

  468. COLAMESTA V, Tamburrano A, Barbara A, Gentili A, et al
    Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study.
    PLoS One. 2019;14:e0225326.
    >> Share

  469. KIL LP, Vaneman J, van der Lubbe JEM, Czapska-Casey D, et al
    Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice.
    PLoS One. 2019;14:e0225063.
    >> Share

  470. RYT-HANSEN P, Pedersen AG, Larsen I, Krog JS, et al
    Acute Influenza A virus outbreak in an enzootic infected sow herd: Impact on viral dynamics, genetic and antigenic variability and effect of maternally derived antibodies and vaccination.
    PLoS One. 2019;14:e0224854.
    >> Share

  471. IZQUIERDO-LARA R, Chumbe A, Calderon K, Fernandez-Diaz M, et al
    Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.
    PLoS One. 2019;14:e0209539.
    >> Share

  472. LI C, Xu J, Deng Y, Sun H, et al
    Selection of reference genes for normalization of cranberry (Vaccinium macrocarpon Ait.) gene expression under different experimental conditions.
    PLoS One. 2019;14:e0224798.
    >> Share

  473. TARIMO EAM, Ambikile J, Munseri P, Bakari M, et al
    Perception of potential harm and benefits of HIV vaccine trial participation: A qualitative study from urban Tanzania.
    PLoS One. 2019;14:e0224831.
    >> Share

  474. ERCIBENGOA M, Alonso M, Vicente D, Morales M, et al
    Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping.
    PLoS One. 2019;14:e0212022.
    >> Share

  475. SHENGE JA, Odaibo GN, Olaleye DO
    Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in Nigeria.
    PLoS One. 2019;14:e0210724.
    >> Share

  476. THIELMANN A, Puth MT, Kersting C, Porz J, et al
    Vaccine cold chain in general practices: A prospective study in 75 refrigerators (Keep Cool study).
    PLoS One. 2019;14:e0224972.
    >> Share

  477. QI L, Su K, Xia Y, Tang W, et al
    Enterovirus 71 vaccine acceptance among parents of children < 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017.
    PLoS One. 2019;14:e0225569.
    >> Share

  478. SISTERE-ORO M, Vergara-Alert J, Stratmann T, Lopez-Serrano S, et al
    Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.
    PLoS One. 2019;14:e0212431.
    >> Share

  479. MIR RA, Schaut RG, Allen HK, Looft T, et al
    Cattle intestinal microbiota shifts following Escherichia coli O157:H7 vaccination and colonizationtravel.
    PLoS One. 2019;14:e0226099.
    >> Share

  480. THIELMANN A, Puth MT, Weltermann B
    Visual inspection of vaccine storage conditions in general practices: A study of 75 vaccine refrigerators.
    PLoS One. 2019;14:e0225764.
    >> Share

  481. Expression of Concern: Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
    PLoS One. 2019;14:e0226124.
    >> Share

  482. HEINSON AI, Ewing RM, Holloway JW, Woelk CH, et al
    An evaluation of different classification algorithms for protein sequence-based reverse vaccinology prediction.
    PLoS One. 2019;14:e0226256.
    >> Share

  483. Correction: An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    PLoS One. 2019;14:e0226706.
    >> Share

  484. ABDO Z, LeCureux J, LaVoy A, Eklund B, et al
    Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice.
    PLoS One. 2019;14:e0225842.
    >> Share

  485. Correction: Cattle intestinal microbiota shifts following Escherichia coli O157:H7 vaccination and colonization.
    PLoS One. 2019;14:e0227403.
    >> Share

  486. COTE-GRAVEL J, Brouillette E, Malouin F
    Vaccination with a live-attenuated small-colony variant improves the humoral and cell-mediated responses against Staphylococcus aureus.
    PLoS One. 2019;14:e0227109.
    >> Share

  487. LOUKA C, Chandler E, Ranchor AV, Broer H, et al
    Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands.
    PLoS One. 2019;14:e0226948.
    >> Share

  488. CRAM JA, Fiore-Gartland AJ, Srinivasan S, Karuna S, et al
    Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination.
    PLoS One. 2019;14:e0225622.
    >> Share

  489. LATTHAPHASAVANG V, Vanhems P, Ngo-Giang-Huong N, Sibounlang P, et al
    Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort study.
    PLoS One. 2019;14:e0215011.
    >> Share

  490. BLEVINS TP, Yu Y, Belshe RB, Bellamy AR, et al
    Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.
    PLoS One. 2019;14:e0214467.
    >> Share

  491. LI Y, Tang X, Zhao Z, Wang H, et al
    Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection.
    PLoS One. 2019;14:e0214596.
    >> Share

  492. ALHARBI A, Rabadi SM, Alqahtani M, Marghani D, et al
    Role of peroxiredoxin of the AhpC/TSA family in antioxidant defense mechanisms of Francisella tularensis.
    PLoS One. 2019;14:e0213699.
    >> Share

  493. SHIMBASHI R, Chang B, Tanabe Y, Takeda H, et al
    Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.
    PLoS One. 2019;14:e0212418.
    >> Share

  494. OLIVEIRA A, Selvaraj K, Tripathy JP, Betodkar U, et al
    Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India-A mixed methods operational research.
    PLoS One. 2019;14:e0226141.
    >> Share

  495. SEO H, Nandre RM, Nietfeld J, Chen Z, et al
    Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
    PLoS One. 2019;14:e0216076.
    >> Share

  496. ARZT J, Fish I, Pauszek SJ, Johnson SL, et al
    The evolution of a super-swarm of foot-and-mouth disease virus in cattle.
    PLoS One. 2019;14:e0210847.
    >> Share

  497. CHENG C, Xu K, Kong R, Chuang GY, et al
    Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
    PLoS One. 2019;14:e0215163.
    >> Share

  498. HANG PHAM TT, Le TX, Nguyen DT, Luu CM, et al
    Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam.
    PLoS One. 2019;14:e0208154.
    >> Share

  499. MATVEEV AL, Kozlova IV, Stronin OV, Khlusevich YA, et al
    Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
    PLoS One. 2019;14:e0215075.
    >> Share

  500. PATEL JS, Quates CJ, Johnson EL, Ytreberg FM, et al
    Expanding the watch list for potential Ebola virus antibody escape mutations.
    PLoS One. 2019;14:e0211093.
    >> Share

  501. RISTIC M, Milosevic V, Medic S, Djekic Malbasa J, et al
    Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.
    PLoS One. 2019;14:e0216219.
    >> Share

  502. PRABDIAL-SING N, Makhathini L, Smit SB, Manamela MJ, et al
    Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.
    PLoS One. 2019;14:e0217415.
    >> Share

  503. HOLMES CL, Peyton CG, Bier AM, Donlon TZ, et al
    Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.
    PLoS One. 2019;14:e0217221.
    >> Share

  504. AO Z, Wang L, Mendoza EJ, Cheng K, et al
    Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.
    PLoS One. 2019;14:e0216949.
    >> Share

  505. NDIZEYE Z, Vanden Broeck D, Lebelo RL, Bogers J, et al
    Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    PLoS One. 2019;14:e0209303.
    >> Share

  506. DE GIER B, van Kassel MN, Sanders EAM, van de Beek D, et al
    Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.
    PLoS One. 2019;14:e0216749.
    >> Share

  507. WANG L, Tan Y, Wei C, Zhang H, et al
    A preliminary study on the application of PspA as a carrier for group A meningococcal polysaccharide.
    PLoS One. 2019;14:e0218427.
    >> Share

  508. STASHKO LA, Gacic-Dobo M, Dumolard LB, Danovaro-Holliday MC, et al
    Assessing the quality and accuracy of national immunization program reported target population estimates from 2000 to 2016.
    PLoS One. 2019;14:e0216933.
    >> Share

  509. CARDOSO AM, Resende PC, Paixao ES, Tavares FG, et al
    Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.
    PLoS One. 2019;14:e0218925.
    >> Share

  510. BHUIYAN MS, Hossain M, Sharmin S, Shirin A, et al
    Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS).
    PLoS One. 2019;14:e0218353.
    >> Share

  511. QURESHI S, Ahmad K, Fatima P, Hassan RM, et al
    Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series.
    PLoS One. 2019;14:e0219324.
    >> Share

  512. CAINI S, Kusznierz G, Garate VV, Wangchuk S, et al
    The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century.
    PLoS One. 2019;14:e0222381.
    >> Share

  513. WANG W, Vassell R, Song HS, Chen Q, et al
    Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
    PLoS One. 2019;14:e0222436.
    >> Share

  514. SABRI A, Quistrebert J, Naji Amrani H, Abid A, et al
    Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    PLoS One. 2019;14:e0221081.
    >> Share

  515. HANG PHAM TT, Le TX, Nguyen DT, Luu CM, et al
    Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam.
    PLoS One. 2019;14:e0223733.
    >> Share

  516. LIND A, Akel O, Wallenius M, Ramelius A, et al
    HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.
    PLoS One. 2019;14:e0222882.
    >> Share

  517. KUROSAWA Y, Sato S, Okuyama T, Taoka M, et al
    Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns.
    PLoS One. 2019;14:e0222199.
    >> Share

  518. LAI CC, Weng TC, Tseng YF, Chiang JR, et al
    Evaluation of novel disposable bioreactors on pandemic influenza virus production.
    PLoS One. 2019;14:e0220803.
    >> Share

  519. POTTER GE, Wong J, Sugimoto J, Diallo A, et al
    Networks of face-to-face social contacts in Niakhar, Senegal.
    PLoS One. 2019;14:e0220443.
    >> Share

  520. HAU SJ, Mou KT, Bayles DO, Brockmeier SL, et al
    Transcriptomic differences noted in Glaesserella parasuis between growth in broth and on agar.
    PLoS One. 2019;14:e0220365.
    >> Share

  521. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    >> Share

  522. DUNNE EM, Choummanivong M, Neal EFG, Stanhope K, et al
    Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR.
    PLoS One. 2019;14:e0224392.
    >> Share

  523. NJOUOM R, Monamele CG, Munshili Njifon HL, Kenmoe S, et al
    Circulation of influenza virus from 2009 to 2018 in Cameroon: 10 years of surveillance data.
    PLoS One. 2019;14:e0225793.
    >> Share

  524. CHANDRA J, Woo WP, Dutton JL, Xu Y, et al
    Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial.
    PLoS One. 2019;14:e0226320.
    >> Share

  525. WIJAYASRI S, Hillier K, Lim GH, Harris TM, et al
    The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.
    PLoS One. 2019;14:e0226353.
    >> Share

  526. TAPIA F, Wohlfarth D, Sandig V, Jordan I, et al
    Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    PLoS One. 2019;14:e0224317.
    >> Share

  527. NEJO YT, Olaleye DO, Odaibo GN
    Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria.
    PLoS One. 2019;14:e0224748.
    >> Share

  528. KING HAD, Gonelli CA, Tullett KM, Lahoud MH, et al
    Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting.
    PLoS One. 2019;14:e0220986.
    >> Share

    January 2018
  529. WU PW, Huang CC, Chao WC, Sun CC, et al
    Impact of influenza vaccine on childhood otitis media in Taiwan: A population-based study.
    PLoS One. 2018;13:e0190507.
    >> Share

  530. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0189571.
    >> Share

  531. CHOI YJ, Park SJ, Park YS, Park HS, et al
    EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0190638.
    >> Share

  532. ZUST R, Li SH, Xie X, Velumani S, et al
    Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
    PLoS One. 2018;13:e0189262.
    >> Share

  533. WALLACE RM, Lai Y, Doty JB, Chen CC, et al
    Initial pen and field assessment of baits to use in oral rabies vaccination of Formosan ferret-badgers in response to the re-emergence of rabies in Taiwan.
    PLoS One. 2018;13:e0189998.
    >> Share

  534. MBULAWA ZZA, van Schalkwyk C, Hu NC, Meiring TL, et al
    High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.
    PLoS One. 2018;13:e0190166.
    >> Share

  535. TARIGAN S, Wibowo MH, Indriani R, Sumarningsih S, et al
    Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.
    PLoS One. 2018;13:e0190947.
    >> Share

  536. CAROLAN K, Verran J, Crossley M, Redfern J, et al
    Impact of educational interventions on adolescent attitudes and knowledge regarding vaccination: A pilot study.
    PLoS One. 2018;13:e0190984.
    >> Share

  537. NOYCE RS, Lederman S, Evans DH
    Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.
    PLoS One. 2018;13:e0188453.
    >> Share

  538. HAMMAMI P, Lancelot R, Domenech J, Lesnoff M, et al
    Ex-ante assessment of different vaccination-based control schedules against the peste des petits ruminants virus in sub-Saharan Africa.
    PLoS One. 2018;13:e0190296.
    >> Share

  539. KIM AR, Lee DH, Lee SH, Rubino I, et al
    Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
    PLoS One. 2018;13:e0191277.
    >> Share

  540. FERNANDEZ-ARIAS C, Arias CF, Zhang M, Herrero MA, et al
    Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines.
    PLoS One. 2018;13:e0190940.
    >> Share

  541. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Correction: Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2018;13:e0191378.
    >> Share

  542. LEE YT, Ko EJ, Lee Y, Kim KH, et al
    Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.
    PLoS One. 2018;13:e0190868.
    >> Share

  543. BAUMGAERTNER B, Carlisle JE, Justwan F
    The influence of political ideology and trust on willingness to vaccinate.
    PLoS One. 2018;13:e0191728.
    >> Share

  544. KIM H, Kimoto T, Sakai S, Takahashi E, et al
    Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice.
    PLoS One. 2018;13:e0191133.
    >> Share

  545. HARALAMBIEVA IH, Kennedy RB, Simon WL, Goergen KM, et al
    Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.
    PLoS One. 2018;13:e0191812.
    >> Share

  546. OPRIESSNIG T, Gauger PC, Gerber PF, Castro AMMG, et al
    Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.
    PLoS One. 2018;13:e0191739.
    >> Share

  547. ALLARD D, Charlebois R, Gilbert L, Stagg J, et al
    CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination.
    PLoS One. 2018;13:e0191973.
    >> Share

  548. TUTYKHINA I, Esmagambetov I, Bagaev A, Pichugin A, et al
    Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.
    PLoS One. 2018;13:e0191574.
    >> Share

  549. CASTOR T, Yogev N, Blank T, Barwig C, et al
    Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.
    PLoS One. 2018;13:e0191927.
    >> Share

  550. SASAKI E, Momose H, Hiradate Y, Furuhata K, et al
    Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.
    PLoS One. 2018;13:e0191896.
    >> Share

  551. GRANDAHL M, Chun Paek S, Grisurapong S, Sherer P, et al
    Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0193054.
    >> Share

  552. VERANI JR, Massora S, Acacio S, Dos Santos RT, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among HIV-infected and -uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique.
    PLoS One. 2018;13:e0191113.
    >> Share

  553. GIACOMET V, Masetti M, Nannini P, Forlanini F, et al
    Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults.
    PLoS One. 2018;13:e0192638.
    >> Share

  554. WILSON SE, Chung H, Schwartz KL, Guttmann A, et al
    Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.
    PLoS One. 2018;13:e0192809.
    >> Share

  555. BASKIN E
    Increasing influenza vaccination rates via low cost messaging interventions.
    PLoS One. 2018;13:e0192594.
    >> Share

  556. SHAH MP, Dahl RM, Parashar UD, Lopman BA, et al
    Annual changes in rotavirus hospitalization rates before and after rotavirus vaccine implementation in the United States.
    PLoS One. 2018;13:e0191429.
    >> Share

  557. HALL MT, Simms KT, Lew JB, Smith MA, et al
    Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.
    PLoS One. 2018;13:e0185332.
    >> Share

  558. KAWAKAMI R, Nozato Y, Nakagami H, Ikeda Y, et al
    Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.
    PLoS One. 2018;13:e0191895.
    >> Share

  559. LEE RU, Won SH, Hansen C, Crum-Cianflone NF, et al
    25-hydroxyvitamin D, influenza vaccine response and healthcare encounters among a young adult population.
    PLoS One. 2018;13:e0192479.
    >> Share

  560. THORRINGTON D, van Rossum L, Knol M, de Melker H, et al
    Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.
    PLoS One. 2018;13:e0192640.
    >> Share

  561. BERKHOUT C, Willefert-Bouche A, Chazard E, Zgorska-Maynard-Moussa S, et al
    Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms.
    PLoS One. 2018;13:e0192155.
    >> Share

  562. NEWMAN LP, Bhat N, Fleming JA, Neuzil KM, et al
    Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016.
    PLoS One. 2018;13:e0193263.
    >> Share

  563. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0192312.
    >> Share

  564. BISSA M, Forlani G, Zanotto C, Tosi G, et al
    Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes.
    PLoS One. 2018;13:e0190869.
    >> Share

  565. SIGAUQUE B, Kobayashi M, Vubil D, Nhacolo A, et al
    Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.
    PLoS One. 2018;13:e0191193.
    >> Share

  566. YOSHIKAWA T, Fujii H, Okutani A, Shibamura M, et al
    Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
    PLoS One. 2018;13:e0192725.
    >> Share

  567. Correction: Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2018;13:e0193631.
    >> Share

  568. WOOD PL, Steinman M, Erol E, Carter C, et al
    Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses.
    PLoS One. 2018;13:e0193424.
    >> Share

  569. SCHERER AM, Schacht Reisinger H, Schweizer ML, Askelson NM, et al
    Cross-sectional associations between psychological traits, and HPV vaccine uptake and intentions in young adults from the United States.
    PLoS One. 2018;13:e0193363.
    >> Share

  570. WHITE M, Freistaedter A, Jones GJB, Zervos E, et al
    Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
    PLoS One. 2018;13:e0193131.
    >> Share

  571. XU K, Zhao Q, Wen X, Wu R, et al
    A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.
    PLoS One. 2018;13:e0191286.
    >> Share

  572. MOR Z, Amit Aharon A, Sheffer R, Nehama H, et al
    Growth, developmental achievements and vaccines timeliness of undocumented migrant children from Eritrea compared with Israelis.
    PLoS One. 2018;13:e0193219.
    >> Share

  573. GONZALEZ-SANCHEZ ME, Cuquerella M, Alunda JM
    Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose.
    PLoS One. 2018;13:e0193118.
    >> Share

  574. YUEN WWY, Lee A, Chan PKS, Tran L, et al
    Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents.
    PLoS One. 2018;13:e0194159.
    >> Share

  575. FERNANDO N, Natoli R, Racic T, Wooff Y, et al
    The use of the vaccinia virus complement control protein (VCP) in the rat retina.
    PLoS One. 2018;13:e0193740.
    >> Share

  576. EBRAHIMI-NIK H, Bassami MR, Mohri M, Rad M, et al
    Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
    PLoS One. 2018;13:e0194888.
    >> Share

  577. CASALINO E, Ghazali A, Bouzid D, Antoniol S, et al
    Patient's behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient's influenza vaccine uptake.
    PLoS One. 2018;13:e0193029.
    >> Share

  578. ASHHURST AS, Parumasivam T, Chan JGY, Lin LCW, et al
    PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0194620.
    >> Share

  579. ANDREAE CA, Sessions RB, Virji M, Hill DJ, et al
    Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.
    PLoS One. 2018;13:e0193940.
    >> Share

  580. VISSERS M, Wijmenga-Monsuur AJ, Knol MJ, Badoux P, et al
    Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.
    PLoS One. 2018;13:e0194823.
    >> Share

  581. NAPOLITANO F, Navaro M, Vezzosi L, Santagati G, et al
    Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy.
    PLoS One. 2018;13:e0194920.
    >> Share

  582. HACHIYA M, Miyano S, Mori Y, Vynnycky E, et al
    Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    PLoS One. 2018;13:e0194931.
    >> Share

  583. SHAHID MA, Marenda MS, Markham PF, Noormohammadi AH, et al
    Complementation of the Mycoplasma synoviae MS-H vaccine strain with wild-type obg influencing its growth characteristics.
    PLoS One. 2018;13:e0194528.
    >> Share

  584. JANG H, Elaish M, Kc M, Abundo MC, et al
    Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
    PLoS One. 2018;13:e0195285.
    >> Share

  585. GRAY DW, Welsh MD, Mansoor F, Doherty S, et al
    DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles.
    PLoS One. 2018;13:e0194488.
    >> Share

  586. TRAMUTO F, Maida CM, Pojero F, Colomba GME, et al
    Case-based surveillance of measles in Sicily during 2012-2017: The changing molecular epidemiology and implications for vaccine strategies.
    PLoS One. 2018;13:e0195256.
    >> Share

  587. RAJENDRAN M, Sun W, Comella P, Nachbagauer R, et al
    An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    PLoS One. 2018;13:e0194830.
    >> Share

  588. OVERTON ET, Lawrence SJ, Wagner E, Nopora K, et al
    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.
    PLoS One. 2018;13:e0195897.
    >> Share

  589. SHERMAN SM, Nailer E
    Attitudes towards and knowledge about Human Papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK.
    PLoS One. 2018;13:e0195801.
    >> Share

  590. ZHOU JJ, Wang YM, Lee VWS, Zhang GY, et al
    DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
    PLoS One. 2018;13:e0195657.
    >> Share

  591. WANG J, Hilchey SP, DeDiego M, Perry S, et al
    Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
    PLoS One. 2018;13:e0193680.
    >> Share

  592. GUARDO AC, Gomez CE, Diaz-Brito V, Pich J, et al
    Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2018;13:e0195915.
    >> Share

  593. GRANDAHL M, Paek SC, Grisurapong S, Sherer P, et al
    Correction: Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0196437.
    >> Share

  594. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0196367.
    >> Share

  595. VAN RAVENHORST MB, den Hartog G, van der Klis FRM, van Rooijen DM, et al
    Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
    PLoS One. 2018;13:e0191261.
    >> Share

  596. MARLET J, Gaudy-Graffin C, Marc D, Boennec R, et al
    Factors associated with influenza vaccination failure and severe disease in a French region in 2015.
    PLoS One. 2018;13:e0195611.
    >> Share

  597. AKAPIRAT S, Karnasuta C, Vasan S, Rerks-Ngarm S, et al
    Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
    PLoS One. 2018;13:e0196397.
    >> Share

  598. TOVAR C, Patchett AL, Kim V, Wilson R, et al
    Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    PLoS One. 2018;13:e0196469.
    >> Share

  599. VOYSEY M, Pollard AJ, Perera R, Shrestha S, et al
    Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
    PLoS One. 2018;13:e0196200.
    >> Share

  600. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0196546.
    >> Share

  601. DORAN RC, Tatsuno GP, O'Rourke SM, Yu B, et al
    Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
    PLoS One. 2018;13:e0196370.
    >> Share

  602. MCCORMICK AA, Shakeel A, Yi C, Kaur H, et al
    Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    PLoS One. 2018;13:e0194614.
    >> Share

  603. GIL DE LOS SANTOS D, Gil de Los Santos JR, Gil-Turnes C, Gaboardi G, et al
    Probiotic effect of Pichia pastoris X-33 produced in parboiled rice effluent and YPD medium on broiler chickens.
    PLoS One. 2018;13:e0192904.
    >> Share

  604. LEUNG-THEUNG-LONG S, Coupet CA, Gouanvic M, Schmitt D, et al
    A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0196815.
    >> Share

  605. KHAN A, Junaid M, Kaushik AC, Ali A, et al
    Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches.
    PLoS One. 2018;13:e0196484.
    >> Share

  606. NUISMER SL, May R, Basinski A, Remien CH, et al
    Controlling epidemics with transmissible vaccines.
    PLoS One. 2018;13:e0196978.
    >> Share

  607. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    >> Share

  608. BUMGARDNER SA, Zhang L, LaVoy AS, Andre B, et al
    Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.
    PLoS One. 2018;13:e0196950.
    >> Share

  609. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0196564.
    >> Share

  610. BORTHWICK NJ, Lane T, Moyo N, Crook A, et al
    Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
    PLoS One. 2018;13:e0197299.
    >> Share

  611. PAULY M, Black AP, Khampanisong P, Nouanthong P, et al
    Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.
    PLoS One. 2018;13:e0197370.
    >> Share

  612. MARLEY KB, Kuehn LA, Keele JW, Wileman BW, et al
    Genetic variation in humoral response to an Escherichia coli O157:H7 vaccine in beef cattle.
    PLoS One. 2018;13:e0197347.
    >> Share

  613. MUELLER SW, Baumgartner LJ, MacLaren R, Neumann R, et al
    Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients.
    PLoS One. 2018;13:e0197037.
    >> Share

  614. MANOHARAN VK, Varghese BP, Paldurai A, Samal SK, et al
    Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    PLoS One. 2018;13:e0197253.
    >> Share

  615. NEIRA V, Allerson M, Corzo C, Culhane M, et al
    Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.
    PLoS One. 2018;13:e0197600.
    >> Share

  616. HUANG Z, Sun X, Wagner AL, Ren J, et al
    Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China.
    PLoS One. 2018;13:e0197437.
    >> Share

  617. Correction: Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0198577.
    >> Share

  618. SELLENS E, Norris JM, Dhand NK, Heller J, et al
    Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.
    PLoS One. 2018;13:e0198421.
    >> Share

  619. ILYINSKII PO, Kovalev GI, O'Neil CP, Roy CJ, et al
    Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
    PLoS One. 2018;13:e0197694.
    >> Share

  620. SHENG X, Liu M, Liu H, Tang X, et al
    Identification of immunogenic proteins and evaluation of recombinant PDHA1 and GAPDH as potential vaccine candidates against Streptococcus iniae infection in flounder (Paralichthys olivaceus).
    PLoS One. 2018;13:e0195450.
    >> Share

  621. LIU M, Huang M, Shui Y, Biville F, et al
    Roles of B739_1343 in iron acquisition and pathogenesis in Riemerella anatipestifer CH-1 and evaluation of the RA-CH-1DeltaB739_1343 mutant as an attenuated vaccine.
    PLoS One. 2018;13:e0197310.
    >> Share

  622. CAYROU C, Akinduko AA, Mirkes EM, Lucidarme J, et al
    Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
    PLoS One. 2018;13:e0197186.
    >> Share

  623. KOOIJMAN S, Brummelman J, van Els CACM, Marino F, et al
    Vaccine antigens modulate the innate response of monocytes to Al(OH)3.
    PLoS One. 2018;13:e0197885.
    >> Share

  624. DE PASCALIS R, Hahn A, Brook HM, Ryden P, et al
    A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    PLoS One. 2018;13:e0198140.
    >> Share

  625. SOUTHERN J, Andrews N, Sandu P, Sheppard CL, et al
    Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
    PLoS One. 2018;13:e0195799.
    >> Share

  626. KUCHENBECKER U, Chase D, Reichert A, Schiffner-Rohe J, et al
    Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
    PLoS One. 2018;13:e0197905.
    >> Share

  627. IMAI C, Toizumi M, Hall L, Lambert S, et al
    A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    PLoS One. 2018;13:e0198685.
    >> Share

  628. SHAHRUDIN S, Chen C, David SC, Singleton EV, et al
    Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.
    PLoS One. 2018;13:e0198182.
    >> Share

  629. POTTINGER HL, Jacobs ET, Haenchen SD, Ernst KC, et al
    Parental attitudes and perceptions associated with childhood vaccine exemptions in high-exemption schools.
    PLoS One. 2018;13:e0198655.
    >> Share

  630. MOHAMMED H, Clarke M, Koehler A, Watson M, et al
    Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.
    PLoS One. 2018;13:e0197867.
    >> Share

  631. TAYLOR WD JR, Langham GL, Weed JL, Rowe T, et al
    The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.
    PLoS One. 2018;13:e0195903.
    >> Share

  632. LASSETER G, Al-Janabi H, Trotter CL, Carroll FE, et al
    The views of the general public on prioritising vaccination programmes against childhood diseases: A qualitative study.
    PLoS One. 2018;13:e0197374.
    >> Share

  633. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    >> Share

  634. GROPPO R, DiNapoli J, Il Jeong K, Kishko M, et al
    Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.
    PLoS One. 2018;13:e0199452.
    >> Share

  635. SU JR, Ng C, Lewis PW, Cano MV, et al
    Adverse events after vaccination among HIV-positive persons, 1990-2016.
    PLoS One. 2018;13:e0199229.
    >> Share

  636. CHIT A, Zivaripiran H, Shin T, Lee JKH, et al
    Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.
    PLoS One. 2018;13:e0197970.
    >> Share

  637. CHEUNG T, Lau JTF, Wang JZ, Mo PKH, et al
    Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong.
    PLoS One. 2018;13:e0198615.
    >> Share

  638. HORSINGTON J, Nfon C, Bittner H, Durr PA, et al
    The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia.
    PLoS One. 2018;13:e0195302.
    >> Share

  639. DE SMEDT T, Merrall E, Macina D, Perez-Vilar S, et al
    Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.
    PLoS One. 2018;13:e0199180.
    >> Share

  640. NYARI S, Khan SA, Rawlinson G, Waugh CA, et al
    Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
    PLoS One. 2018;13:e0200112.
    >> Share

  641. WU AG, Shah AS, Haelle TS, Lunos SA, et al
    Choosing the perfect shot - The loaded narrative of imagery in online news coverage of vaccines.
    PLoS One. 2018;13:e0199870.
    >> Share

  642. ZARNITSYNA VI, Bulusheva I, Handel A, Longini IM, et al
    Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.
    PLoS One. 2018;13:e0199674.
    >> Share

  643. IMAI N, Ferguson NM
    Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design.
    PLoS One. 2018;13:e0199450.
    >> Share

  644. KARAMPATSAS K, Osborne L, Seah ML, Tong CYW, et al
    Clinical characteristics and complications of rotavirus gastroenteritis in children in east London: A retrospective case-control study.
    PLoS One. 2018;13:e0194009.
    >> Share

  645. PALING FP, Olsen K, Ohneberg K, Wolkewitz M, et al
    Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.
    PLoS One. 2018;13:e0193445.
    >> Share

  646. ANDERSON KB, Simasathien S, Watanaveeradej V, Weg AL, et al
    Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.
    PLoS One. 2018;13:e0193050.
    >> Share

  647. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0199249.
    >> Share

  648. SUBAIYA S, Tabu C, N'ganga J, Awes AA, et al
    Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    PLoS One. 2018;13:e0199786.
    >> Share

  649. SEKULOSKI S, Batzloff MR, Griffin P, Parsonage W, et al
    Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial.
    PLoS One. 2018;13:e0198658.
    >> Share

  650. PORTER CK, Lynen A, Riddle MS, Talaat K, et al
    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.
    PLoS One. 2018;13:e0194325.
    >> Share

  651. LEE KS, Lee YR, Park SY, Oh IH, et al
    The economic burden of rotavirus infection in South Korea from 2009 to 2012.
    PLoS One. 2018;13:e0194120.
    >> Share

  652. JUNG M
    The effect of maternal decisional authority on children's vaccination in East Asia.
    PLoS One. 2018;13:e0200333.
    >> Share

  653. MARBAIX S, Peetermans WE, Verhaegen J, Annemans L, et al
    Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.
    PLoS One. 2018;13:e0199427.
    >> Share

  654. ABDUL-CADER MS, Amarasinghe A, Palomino-Tapia V, Ahmed-Hassan H, et al
    In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection.
    PLoS One. 2018;13:e0193964.
    >> Share

  655. GENTILE A, Bakir J, Firpo V, Casanueva EV, et al
    PCV13 vaccination impact: A multicenter study of pneumonia in 10 pediatric hospitals in Argentina.
    PLoS One. 2018;13:e0199989.
    >> Share

  656. MERIKI HD, Tufon KA, Anong DN, Tony NJ, et al
    Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon.
    PLoS One. 2018;13:e0200157.
    >> Share

  657. WEN Y, Trinh HV, Linton CE, Tani C, et al
    Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
    PLoS One. 2018;13:e0194266.
    >> Share

  658. GIBSON AD, Mazeri S, Lohr F, Mayer D, et al
    One million dog vaccinations recorded on mHealth innovation used to direct teams in numerous rabies control campaigns.
    PLoS One. 2018;13:e0200942.
    >> Share

  659. SHEN K, Wasserman M, Liu D, Yang YH, et al
    Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China.
    PLoS One. 2018;13:e0201245.
    >> Share

  660. OMINDE M, Sande J, Ooko M, Bottomley C, et al
    Reliability and validity of the World Health Organization reading standards for paediatric chest radiographs used in the field in an impact study of Pneumococcal Conjugate Vaccine in Kilifi, Kenya.
    PLoS One. 2018;13:e0200715.
    >> Share

  661. LEE HS, Thiem VD, Anh DD, Duong TN, et al
    Geographical and temporal patterns of rabies post exposure prophylaxis (PEP) incidence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015.
    PLoS One. 2018;13:e0194943.
    >> Share

  662. LIANG H, Yang R, Liu Z, Li M, et al
    Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    PLoS One. 2018;13:e0194860.
    >> Share

  663. KAUFMAN J, Ryan R, Hill S
    Qualitative focus groups with stakeholders identify new potential outcomes related to vaccination communication.
    PLoS One. 2018;13:e0201145.
    >> Share

  664. BAKER DL, Powers JG, Ransom JI, McCann BE, et al
    Reimmunization increases contraceptive effectiveness of gonadotropin-releasing hormone vaccine (GonaCon-Equine) in free-ranging horses (Equus caballus): Limitations and side effects.
    PLoS One. 2018;13:e0201570.
    >> Share

  665. LEE MF, Chiang CH, Li YL, Wang NM, et al
    Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model.
    PLoS One. 2018;13:e0201281.
    >> Share

  666. MAZAGATOS C, Delgado-Sanz C, Oliva J, Gherasim A, et al
    Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
    PLoS One. 2018;13:e0200934.
    >> Share

  667. MUNGUAMBE AM, de Almeida AECC, Nhantumbo AA, Come CE, et al
    Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    PLoS One. 2018;13:e0197390.
    >> Share

  668. PURRINOS-HERMIDA MJ, Santiago-Perez MI, Trevino M, Dopazo R, et al
    Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain.
    PLoS One. 2018;13:e0201653.
    >> Share

  669. BROWN DW, Tabu C, Sergon K, Shendale S, et al
    Home-based record (HBR) ownership and use of HBR recording fields in selected Kenyan communities: Results from the Kenya Missed Opportunities for Vaccination Assessment.
    PLoS One. 2018;13:e0201538.
    >> Share

  670. O'ROURKE SM, Byrne G, Tatsuno G, Wright M, et al
    Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production.
    PLoS One. 2018;13:e0197656.
    >> Share

  671. RENIER W, Bourdin A, Rubbo PA, Peries M, et al
    B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    PLoS One. 2018;13:e0196470.
    >> Share

  672. POSUWAN N, Vorayingyong A, Jaroonvanichkul V, Wasitthankasem R, et al
    Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    PLoS One. 2018;13:e0202637.
    >> Share

  673. RANFAING J, Dunyach-Remy C, Lavigne JP, Sotto A, et al
    Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli.
    PLoS One. 2018;13:e0202609.
    >> Share

  674. KLYZ A, Piekarowicz A
    Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates.
    PLoS One. 2018;13:e0202437.
    >> Share

  675. TSYBALOVA LM, Stepanova LA, Shuklina MA, Mardanova ES, et al
    Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    PLoS One. 2018;13:e0201429.
    >> Share

  676. MARITAN M, Veggi D, Cozzi R, Dello Iacono L, et al
    Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody.
    PLoS One. 2018;13:e0201922.
    >> Share

  677. AL MAHTAB M, Akbar SMF, Aguilar JC, Guillen G, et al
    Treatment of chronic hepatitis B naive patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).
    PLoS One. 2018;13:e0201236.
    >> Share

  678. Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2018;13:e0203635.
    >> Share

  679. MUNUSAMY PONNAN S, Swaminathan S, Tiruvengadam K, K K V, et al
    Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0203037.
    >> Share

  680. LI H, Hai Y, Lim SY, Toledo N, et al
    Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
    PLoS One. 2018;13:e0202997.
    >> Share

  681. SANAPALA S, Mosca L, Wang S, Curtiss R, et al
    Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence.
    PLoS One. 2018;13:e0203526.
    >> Share

  682. VOYSEY M, Sadarangani M, Pollard AJ, Fanshawe TR, et al
    Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias.
    PLoS One. 2018;13:e0202517.
    >> Share

  683. BOZIO CH, Abdul-Karim A, Abenyeri J, Abubakari B, et al
    Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2018;13:e0203205.
    >> Share

  684. HEGERLE N, Choi M, Sinclair J, Amin MN, et al
    Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    PLoS One. 2018;13:e0203143.
    >> Share

  685. MATTHIJSSE SM, Naber SK, Hontelez JAC, Bakker R, et al
    The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.
    PLoS One. 2018;13:e0202924.
    >> Share

  686. LI J, Helal ZH, Karch CP, Mishra N, et al
    A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.
    PLoS One. 2018;13:e0203771.
    >> Share

  687. HOWLADER DR, Koley H, Sinha R, Maiti S, et al
    Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.
    PLoS One. 2018;13:e0203631.
    >> Share

  688. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    >> Share

  689. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2018;13:e0204759.
    >> Share

  690. ELIZAGA ML, Li SS, Kochar NK, Wilson GJ, et al
    Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
    PLoS One. 2018;13:e0202753.
    >> Share

  691. Correction: Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0204476.
    >> Share

  692. BALOGUN F, Omotade O
    "She must have been sleeping around"...: Contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria.
    PLoS One. 2018;13:e0203950.
    >> Share

  693. ALLEN JD, Ray S, Ross TM
    Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0204284.
    >> Share

  694. ROSTAMIAN M, Bahrami F, Niknam HM
    Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    PLoS One. 2018;13:e0204491.
    >> Share

  695. SEMA BALTAZAR C, Rafael F, Langa JPM, Chicumbe S, et al
    Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    PLoS One. 2018;13:e0198592.
    >> Share

  696. SOBHKHEZ M, Krasnov A, Robertsen B
    Transcriptome analyses of Atlantic salmon muscle genes induced by a DNA vaccine against salmonid alphavirus, the causative agent of salmon pancreas disease (PD).
    PLoS One. 2018;13:e0204924.
    >> Share

  697. BAETEN LA, Podell BK, Sluder AE, Garritsen A, et al
    Standardized guinea pig model for Q fever vaccine reactogenicity.
    PLoS One. 2018;13:e0205882.
    >> Share

  698. LAU JTF, Ng CSM, Wu AMS, Ma YL, et al
    Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors.
    PLoS One. 2018;13:e0205561.
    >> Share

  699. DA SILVA EN, Baker A, Alshekaili J, Karpe K, et al
    A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.
    PLoS One. 2018;13:e0204477.
    >> Share

  700. TONUI T, Corredor-Moreno P, Kanduma E, Njuguna J, et al
    Transcriptomics reveal potential vaccine antigens and a drastic increase of upregulated genes during Theileria parva development from arthropod to bovine infective stages.
    PLoS One. 2018;13:e0204047.
    >> Share

  701. ISHIMURA ME, Teixeira D, Silveira GDP, Gambero M, et al
    Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.
    PLoS One. 2018;13:e0205148.
    >> Share

  702. WHELAN AO, Flick-Smith HC, Homan J, Shen ZT, et al
    Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
    PLoS One. 2018;13:e0200213.
    >> Share

  703. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0205567.
    >> Share

  704. PARK S, Lee Y, Kwon YM, Lee YT, et al
    Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge.
    PLoS One. 2018;13:e0205071.
    >> Share

  705. LI Z, Swann JL, Keskinocak P
    Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.
    PLoS One. 2018;13:e0206293.
    >> Share

  706. JACKSON ML, Diallo AO, Medah I, Bicaba BW, et al
    Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt.
    PLoS One. 2018;13:e0206117.
    >> Share

    System dynamics modelling approach to explore the effect of dog demography on rabies vaccination coverage in Africa.
    PLoS One. 2018;13:e0205884.
    >> Share

  708. CAMPBELL ZA, Marsh TL, Mpolya EA, Thumbi SM, et al
    Newcastle disease vaccine adoption by smallholder households in Tanzania: Identifying determinants and barriers.
    PLoS One. 2018;13:e0206058.
    >> Share

  709. O'MALLEY KJ, Bowling JL, Stinson E, Cole KS, et al
    Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0205928.
    >> Share

  710. HORACIO AN, Silva-Costa C, Lopes E, Ramirez M, et al
    Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
    PLoS One. 2018;13:e0206912.
    >> Share

  711. HOUSER KV, Yamshchikov GV, Bellamy AR, May J, et al
    DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
    PLoS One. 2018;13:e0206837.
    >> Share

  712. NYASANI DK, Mutua GN, Sajabi RM, Ng'ang'a JW, et al
    Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    PLoS One. 2018;13:e0206656.
    >> Share

  713. LI X, Doroshenko A, Osgood ND
    Applying particle filtering in both aggregated and age-structured population compartmental models of pre-vaccination measles.
    PLoS One. 2018;13:e0206529.
    >> Share

  714. CARTER SP, Robertson A, Palphramand KL, Chambers MA, et al
    Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis.
    PLoS One. 2018;13:e0206136.
    >> Share

  715. ZHAO H, Xu K, Jiang Z, Shao M, et al
    A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.
    PLoS One. 2018;13:e0207431.
    >> Share

  716. Correction: Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0207721.
    >> Share

  717. BECK KB, Honge BL, Olesen JS, Petersen MS, et al
    Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women.
    PLoS One. 2018;13:e0207259.
    >> Share

  718. JAIN A, Walker JL, Mathur R, Forbes HJ, et al
    Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink.
    PLoS One. 2018;13:e0207183.
    >> Share

  719. STEPHENSON KE, Keefer MC, Bunce CA, Frances D, et al
    First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
    PLoS One. 2018;13:e0205139.
    >> Share

  720. WONDIMENEH Y, Tiruneh M, Ferede G, Denekew K, et al
    Hospital based surveillance of congenital rubella syndrome cases in the pre-vaccine era in Amhara Regional State, Ethiopia: A base line information for the country.
    PLoS One. 2018;13:e0207095.
    >> Share

  721. ABU SEIR R, Azmi K, Hamdan A, Namouz H, et al
    Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).
    PLoS One. 2018;13:e0206927.
    >> Share

  722. MENDES LOBAO W, Duarte FG, Burns JD, de Souza Teles Santos CA, et al
    Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery?
    PLoS One. 2018;13:e0206726.
    >> Share

  723. MARX M, Zumpe M, Troschke-Meurer S, Shah D, et al
    Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    PLoS One. 2018;13:e0207320.
    >> Share

  724. VIEGAS EO, Kroidl A, Munseri PJ, Missanga M, et al
    Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
    PLoS One. 2018;13:e0206838.
    >> Share

  725. CASSIOLATO AP, Almeida SCG, Andrade AL, Minamisava R, et al
    Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.
    PLoS One. 2018;13:e0208211.
    >> Share

  726. GRACE D, Gaspar M, Paquette R, Rosenes R, et al
    HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study.
    PLoS One. 2018;13:e0207953.
    >> Share

  727. KHAN J, Shil A, Prakash R
    Exploring the spatial heterogeneity in different doses of vaccination coverage in India.
    PLoS One. 2018;13:e0207209.
    >> Share

  728. SONG IG, Lee H, Yi J, Kim MS, et al
    Health literacy and use of preventive health services among North Korean defectors in the Republic of Korea.
    PLoS One. 2018;13:e0195964.
    >> Share

  729. BARBOSA COSTA G, Gilbert A, Monroe B, Blanton J, et al
    The influence of poverty and rabies knowledge on healthcare seeking behaviors and dog ownership, Cameroon.
    PLoS One. 2018;13:e0197330.
    >> Share

  730. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    The relationship between perceptions and self-paid hepatitis B vaccination: A structural equation modeling approach.
    PLoS One. 2018;13:e0208402.
    >> Share

  731. KORSA MG, Devlin JM, Hartley CA, Browning GF, et al
    Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens.
    PLoS One. 2018;13:e0207611.
    >> Share

  732. SONG JY, Noh JY, Lee JS, Wie SH, et al
    Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    PLoS One. 2018;13:e0207918.
    >> Share

  733. RUDENKO L, Kiseleva I, Krutikova E, Stepanova E, et al
    Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    PLoS One. 2018;13:e0208028.
    >> Share

  734. FLAMAR AL, Bonnabau H, Zurawski S, Lacabaratz C, et al
    HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
    PLoS One. 2018;13:e0207794.
    >> Share

  735. REN J, Wagner AL, Zheng A, Sun X, et al
    The demographics of vaccine hesitancy in Shanghai, China.
    PLoS One. 2018;13:e0209117.
    >> Share

  736. PASIN C, Halloran ME, Gilbert PB, Langevin E, et al
    Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.
    PLoS One. 2018;13:e0207878.
    >> Share

  737. TIONO AB, Nebie I, Anagnostou N, Coulibaly AS, et al
    First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
    PLoS One. 2018;13:e0208328.
    >> Share

  738. SUNAGAR R, Kumar S, Namjoshi P, Rosa SJ, et al
    Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.
    PLoS One. 2018;13:e0207587.
    >> Share

  739. BETSCH C, Schmid P, Heinemeier D, Korn L, et al
    Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination.
    PLoS One. 2018;13:e0208601.
    >> Share

  740. ZHANG F, Zhao Q, Quan K, Zhu Z, et al
    Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    PLoS One. 2018;13:e0198207.
    >> Share

  741. KWAN NCL, Yamada A, Sugiura K
    Benefit-cost analysis of the policy of mandatory annual rabies vaccination of domestic dogs in rabies-free Japan.
    PLoS One. 2018;13:e0206717.
    >> Share

  742. HAIWICK G, Hermann J, Roof M, Fergen B, et al
    Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge-dose study.
    PLoS One. 2018;13:e0209784.
    >> Share

  743. KESANOPOULOS K, Bratcher HB, Hong E, Xirogianni A, et al
    Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation.
    PLoS One. 2018;13:e0209919.
    >> Share

  744. ALLEN JD, Ray S, Ross TM
    Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0210043.
    >> Share

  745. AMPARO ACB, Jayme SI, Roces MCR, Quizon MCL, et al
    The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective.
    PLoS One. 2018;13:e0199186.
    >> Share

  746. DE NARDO P, Gentilotti E, Vairo F, Nguhuni B, et al
    A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination.
    PLoS One. 2018;13:e0197996.
    >> Share

  747. NUNES MC, Weinberg A, Cutland CL, Jones S, et al
    Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women.
    PLoS One. 2018;13:e0210124.
    >> Share

  748. DIMALA CA, Kika BT, Kadia BM, Blencowe H, et al
    Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.
    PLoS One. 2018;13:e0209744.
    >> Share

  749. MAKUMBI F, Byabagambi J, Muwanika R, Kigozi G, et al
    Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda.
    PLoS One. 2018;13:e0209167.
    >> Share

  750. PAES W, Dowle A, Coldwell J, Leech A, et al
    The Chlamydia trachomatis PmpD adhesin forms higher order structures through disulphide-mediated covalent interactions.
    PLoS One. 2018;13:e0198662.
    >> Share

  751. THAKUR A, Andrea A, Mikkelsen H, Woodworth JS, et al
    Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves.
    PLoS One. 2018;13:e0201253.
    >> Share

  752. HOSSAIN MU, Omar TM, Alam I, Das KC, et al
    Pathway based therapeutic targets identification and development of an interactive database CampyNIBase of Campylobacter jejuni RM1221 through non-redundant protein dataset.
    PLoS One. 2018;13:e0198170.
    >> Share

  753. JIANG H, Huai Y, Chen H, Uyeki TM, et al
    Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012.
    PLoS One. 2018;13:e0201312.
    >> Share

  754. NIX EB, Choi J, Anthes C, Gaultier GN, et al
    Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    PLoS One. 2018;13:e0201282.
    >> Share

  755. ACHARYA P, Kismul H, Mapatano MA, Hatloy A, et al
    Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis.
    PLoS One. 2018;13:e0202742.
    >> Share

  756. STADLER J, Naderer L, Beffort L, Ritzmann M, et al
    Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.
    PLoS One. 2018;13:e0203560.
    >> Share

  757. PILKERTON CS, Hobbs GR, Lilly C, Knox SS, et al
    Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy.
    PLoS One. 2018;13:e0203330.
    >> Share

  758. SARAIVA MMS, Moreira Filho ALB, Freitas Neto OC, Silva NMV, et al
    Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut.
    PLoS One. 2018;13:e0203158.
    >> Share

  759. IN HJ, Lim H, Lee JA, Lee SR, et al
    Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    PLoS One. 2018;13:e0202552.
    >> Share

  760. DODD CN, de Ridder M, Huang WT, Weibel D, et al
    Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    PLoS One. 2018;13:e0204799.
    >> Share

  761. CHONG KC, Hu P, Lau S, Jia KM, et al
    Monitoring the age-specificity of measles transmissions during 2009-2016 in Southern China.
    PLoS One. 2018;13:e0205339.
    >> Share

  762. CHUNG CJ, Cha SH, Grimm AL, Ajithdoss D, et al
    Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells.
    PLoS One. 2018;13:e0203482.
    >> Share

  763. ADAMO G, Sturabotti G, Baccolini V, de Soccio P, et al
    Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    PLoS One. 2018;13:e0205147.
    >> Share

  764. ERDEM G, Singh AK, Brusnahan AJ, Moore AN, et al
    Pneumococcal colonization among tracheostomy tube dependent children.
    PLoS One. 2018;13:e0206305.
    >> Share

  765. MATHEW E, Zhu H, Connelly SM, Sullivan MA, et al
    Display of the HIV envelope protein at the yeast cell surface for immunogen development.
    PLoS One. 2018;13:e0205756.
    >> Share

  766. JUDD A, Foster C, Thompson LC, Sturgeon K, et al
    Sexual health of young people with perinatal HIV and HIV negative young people in England.
    PLoS One. 2018;13:e0205597.
    >> Share

  767. ALKIE TN, Yitbarek A, Taha-Abdelaziz K, Astill J, et al
    Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
    PLoS One. 2018;13:e0206324.
    >> Share

  768. DEBELLUT F, Hendrix N, Ortiz JR, Lambach P, et al
    Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries.
    PLoS One. 2018;13:e0199470.
    >> Share

  769. LAINO J, Villena J, Suvorov A, Zelaya H, et al
    Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
    PLoS One. 2018;13:e0206661.
    >> Share

  770. MANNA S, Dunne EM, Ortika BD, Pell CL, et al
    Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene.
    PLoS One. 2018;13:e0206622.
    >> Share

  771. YIN R, Tran VH, Zhou X, Zheng J, et al
    Predicting antigenic variants of H1N1 influenza virus based on epidemics and pandemics using a stacking model.
    PLoS One. 2018;13:e0207777.
    >> Share

  772. VAN DIEPEN MT, Chapman R, Moore PL, Margolin E, et al
    The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256.
    PLoS One. 2018;13:e0208310.
    >> Share

  773. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
    PLoS One. 2018;13:e0208267.
    >> Share

  774. MORALES M, Ludwig G, Ercibengoa M, Esteva C, et al
    Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain.
    PLoS One. 2018;13:e0209048.
    >> Share

  775. MCSHERRY LA, O'Leary E, Dombrowski SU, Francis JJ, et al
    Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives.
    PLoS One. 2018;13:e0208482.
    >> Share

    January 2017
  776. JIA B, McNeil LK, Dupont CD, Tsioris K, et al
    Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
    PLoS One. 2017;12:e0183738.
    >> Share

  777. KANEKO M, Takanashi S, Thongprachum A, Hanaoka N, et al
    Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015.
    PLoS One. 2017;12:e0184067.
    >> Share

  778. ALAM S, Chan C, Qiu X, Shannon I, et al
    Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    PLoS One. 2017;12:e0176407.
    >> Share

  779. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    >> Share

  780. FRAIBERK M, Hajkova M, Krulova M, Kojzarova M, et al
    Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.
    PLoS One. 2017;12:e0184870.
    >> Share

  781. LUEDERS I, Young D, Maree L, van der Horst G, et al
    Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality.
    PLoS One. 2017;12:e0178270.
    >> Share

  782. EVANGELISTA KV, Lourdault K, Matsunaga J, Haake DA, et al
    Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.
    PLoS One. 2017;12:e0180004.
    >> Share

  783. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    >> Share

  784. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    >> Share

  785. SARTORI AL, Minamisava R, Bierrenbach AL, Toscano CM, et al
    Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.
    PLoS One. 2017;12:e0179222.
    >> Share

  786. PIPKINS HR, Bradshaw JL, Keller LE, Swiatlo E, et al
    Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
    PLoS One. 2017;12:e0179159.
    >> Share

  787. BYBERG S, Ostergaard MD, Rodrigues A, Martins C, et al
    Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.
    PLoS One. 2017;12:e0177984.
    >> Share

  788. WANG G, Yin R, Zhou P, Ding Z, et al
    Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.
    PLoS One. 2017;12:e0176854.
    >> Share

  789. VINOD N, Noh HB, Oh S, Ji S, et al
    A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.
    PLoS One. 2017;12:e0185488.
    >> Share

  790. FABURAY B, McGill J, Jongejan F
    A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep.
    PLoS One. 2017;12:e0185495.
    >> Share

  791. GRIMALDI G JR, Teva A, Dos-Santos CB, Santos FN, et al
    Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    PLoS One. 2017;12:e0185438.
    >> Share

  792. ROSAS-UMBERT M, Mothe B, Noguera-Julian M, Bellido R, et al
    Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
    PLoS One. 2017;12:e0184929.
    >> Share

  793. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    >> Share

  794. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    >> Share

  795. HSU AP, Tseng CH, Barrat J, Lee SH, et al
    Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers.
    PLoS One. 2017;12:e0184831.
    >> Share

  796. CAPUCCI S, Wee EG, Schiffner T, LaBranche CC, et al
    HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
    PLoS One. 2017;12:e0181886.
    >> Share

  797. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    >> Share

  798. PEREZ LG, Martinez DR, deCamp AC, Pinter A, et al
    V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
    PLoS One. 2017;12:e0180720.
    >> Share

  799. MINAYA MA, Korom M, Wang H, Belshe RB, et al
    The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.
    PLoS One. 2017;12:e0176687.
    >> Share

  800. HASSAN AO, Amen O, Sayedahmed EE, Vemula SV, et al
    Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    PLoS One. 2017;12:e0186244.
    >> Share

  801. FERREYRA-REYES L, Cruz-Hervert LP, Troy SB, Huang C, et al
    Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico.
    PLoS One. 2017;12:e0185594.
    >> Share

  802. MAILYBAYEVA A, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    PLoS One. 2017;12:e0186484.
    >> Share

  803. WARD PR, Attwell K, Meyer SB, Rokkas P, et al
    Understanding the perceived logic of care by vaccine-hesitant and vaccine-refusing parents: A qualitative study in Australia.
    PLoS One. 2017;12:e0185955.
    >> Share

  804. BILLARD MN, De Serres G, Gariepy MC, Boulianne N, et al
    Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.
    PLoS One. 2017;12:e0186070.
    >> Share

  805. MCCURLEY NP, Domi A, Basu R, Saunders KO, et al
    HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
    PLoS One. 2017;12:e0177863.
    >> Share

  806. SMITH SG, Harris SA, Satti I, Bryan D, et al
    Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.
    PLoS One. 2017;12:e0184391.
    >> Share

  807. BOTWRIGHT S, Holroyd T, Nanda S, Bloem P, et al
    Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    PLoS One. 2017;12:e0182663.
    >> Share

  808. GIANINO MM, Politano G, Scarmozzino A, Charrier L, et al
    Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.
    PLoS One. 2017;12:e0182510.
    >> Share

  809. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    >> Share

  810. CHEN SI
    Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
    PLoS One. 2017;12:e0186418.
    >> Share

  811. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    >> Share

  812. HIGGINS JL, Gonzalez-Juarrero M, Bowen RA
    Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
    PLoS One. 2017;12:e0185823.
    >> Share

  813. VAN DEN BIGGELAAR AHJ, Richmond PC, Fuery A, Anderson D, et al
    Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
    PLoS One. 2017;12:e0185877.
    >> Share

  814. DOWELL AC, Cobby E, Wen K, Devall AJ, et al
    Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    PLoS One. 2017;12:e0184841.
    >> Share

  815. CLARK A, Black R, Tate J, Roose A, et al
    Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.
    PLoS One. 2017;12:e0183392.
    >> Share

  816. TI J, Li Z, Li X, Lu Y, et al
    Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies.
    PLoS One. 2017;12:e0181177.
    >> Share

  817. C GUARDO A, Gomez CE, Diaz-Brito V, Pich J, et al
    Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2017;12:e0186602.
    >> Share

  818. KAZADI EK, Tshilenge GM, Mbao V, Njoumemi Z, et al
    Determinants of dog owner-charged rabies vaccination in Kinshasa, Democratic Republic of Congo.
    PLoS One. 2017;12:e0186677.
    >> Share

  819. MONAMELE GC, Vernet MA, Njankouo MR, Victoir K, et al
    Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2017;12:e0184411.
    >> Share

  820. SABET S, George MA, El-Shorbagy HM, Bassiony H, et al
    Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
    PLoS One. 2017;12:e0181723.
    >> Share

  821. ROSE J, Homa L, Meropol SB, Debanne SM, et al
    Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
    PLoS One. 2017;12:e0187446.
    >> Share

  822. GRANDAHL M, Larsson M, Dalianis T, Stenhammar C, et al
    Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour.
    PLoS One. 2017;12:e0187193.
    >> Share

  823. DIALLO AO, Soeters HM, Yameogo I, Sawadogo G, et al
    Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
    PLoS One. 2017;12:e0187466.
    >> Share

  824. ABIR T, Ogbo FA, Stevens GJ, Page AN, et al
    The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.
    PLoS One. 2017;12:e0187090.
    >> Share

  825. NUNEZ IA, Carlock MA, Allen JD, Owino SO, et al
    Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
    PLoS One. 2017;12:e0185666.
    >> Share

  826. CAFIERO-FONSECA ET, Stawasz A, Johnson ST, Sato R, et al
    The full benefits of adult pneumococcal vaccination: A systematic review.
    PLoS One. 2017;12:e0186903.
    >> Share